Qorvo (QRVO) 10-K 20 May 24 2024 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Mar. 30, 2024	May 13, 2024	Sep. 30, 2023
Document and Entity Information [Abstract]
Document Annual Report	true
City Area Code	336
Local Phone Number	664-1233
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Incorporation, State or Country Code	DE
Document Transition Report	false
Entity Central Index Key	0001604778
Entity File Number	001-36801
Document Period End Date	Mar. 30, 2024
Amendment Flag	false
Document Fiscal Period Focus	FY
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Tax Identification Number	46-5288992
Entity Address, Address Line One	7628 Thorndike Road
Entity Address, Postal Zip Code	27409-9421
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Trading Symbol	QRVO
Security Exchange Name	NASDAQ
Document Fiscal Year Focus	2024
Document Type	10-K
Entity Registrant Name	Qorvo, Inc.
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Public Float			$ 9,268,747,530
Entity Common Stock, Shares Outstanding		95,629,095
Internal Control over Financial Reporting filed report	true
Current Fiscal Year End Date	--03-30
Auditor Name	Ernst & Young LLP
Auditor Location	Charlotte, North Carolina
Auditor Firm ID	42
Document Financial Statement Error Correction [Flag]	false

Cover

Cover	12 Months Ended
	Mar. 30, 2024
Cover [Abstract]
Documents Incorporated by Reference	The registrant has incorporated by reference into Part III of this report certain portions of its proxy statement for its 2024 annual meeting of stockholders, which is expected to be filed within 120 days after the end of the registrant’s fiscal year ended March 30, 2024.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 30, 2024	Apr. 01, 2023
Current assets:
Cash and cash equivalents	$ 1,029,258	$ 808,757
Accounts receivable, net of allowance of $313 and $369 as of March 30, 2024 and April 1, 2023, respectively	412,960	304,519
Inventories	710,555	796,596
Prepaid expenses	40,563	46,684
Other Receivables, Net, Current	14,427	26,535
Other current assets	78,993	46,703
Disposal Group, Including Discontinued Operation, Assets	159,278	0
Total current assets	2,446,034	2,029,794
Property and equipment, net	870,982	1,149,806
Goodwill	2,534,601	2,760,813
Intangible assets, net	509,383	537,703
Long-term investments	23,252	20,406
Other non-current assets	170,383	193,381
Total assets	6,554,635	6,691,903
Current liabilities:
Accounts payable	252,993	210,701
Accrued liabilities	336,767	222,463
Long-term Debt, Current Maturities	438,740	310
Other current liabilities	113,215	122,289
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations	88,372	0
Total current liabilities	1,230,087	555,763
Long-term debt	1,549,272	2,048,073
Other long-term liabilities	218,904	185,273
Total liabilities	2,998,263	2,789,109
Commitments and contingent liabilities (Note 12)
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 95,798 and 98,649 shares issued and outstanding at March 30, 2024 and April 1, 2023, respectively	3,651,067	3,821,474
Accumulated other comprehensive loss	(5,097)	(3,175)
Retained Earnings (Accumulated Deficit)	(89,598)	84,495
Total stockholders’ equity	3,556,372	3,902,794
Total liabilities and stockholders’ equity	$ 6,554,635	$ 6,691,903

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 30, 2024	Apr. 01, 2023
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 313	$ 369
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common stock, shares authorized	405,000,000	405,000,000
Common stock, shares issued	95,798,000	98,649,000
Common stock, shares outstanding	95,798,000	98,649,000

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (70,322)	$ 103,152	$ 1,033,353
Other comprehensive loss, net of tax:
Change in pension liability	(123)	1,836	857
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	(1,787)	(10,254)	(25,033)
Reclassification adjustments, net of tax:
Foreign currency gain realized upon liquidation of subsidiary	0	(25)	(359)
Amortization of pension actuarial (gain) loss	(12)	36	118
Other comprehensive loss	(1,922)	(8,407)	(24,417)
Total comprehensive (loss) income	$ (72,244)	$ 94,745	$ 1,008,936

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Income Statement [Abstract]
Revenue	$ 3,769,506	$ 3,569,399	$ 4,645,714
Cost of goods sold	2,281,011	2,272,457	2,359,546
Gross profit	1,488,495	1,296,942	2,286,168
Operating expenses:
Research and development	682,249	649,841	623,636
Selling, general and administrative	389,140	358,790	349,718
Goodwill impairment	221,414	12,411	48,000
Other operating expense	103,991	92,732	38,745
Total operating expenses	1,396,794	1,113,774	1,060,099
Operating income	91,701	183,168	1,226,069
Interest expense	(69,245)	(68,463)	(63,326)
Other income, net	51,104	9,924	18,341
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	73,560	124,629	1,181,084
Income tax expense	143,882	21,477	147,731
Net (loss) income	$ (70,322)	$ 103,152	$ 1,033,353
Basic net (loss) income per share	$ 0.72	$ (1.01)	$ (9.38)
Net (loss) income per share:
Diluted	$ 0.72	$ (1)	$ (9.26)
Weighted-average shares of common stock outstanding:
Basic	97,557	102,206	110,196
Diluted	97,557	103,019	111,546

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Common Stocks, Including Additional Paid in Capital	$ 4,244,740
Accumulated Other Comprehensive Income (Loss), Net of Tax	29,649
Retained Earnings (Accumulated Deficit)	355,036
Beginning Balance at Apr. 03, 2021	$ 4,629,425
Beginning Balance, Shares at Apr. 03, 2021	112,557
Net (loss) income	$ 1,033,353	$ 0	$ 0	$ 1,033,353
Other comprehensive income (loss)	(24,417)	0	(24,417)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (49,798)	(49,798)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	779
Issuance of common stock in connection with employee stock purchase plan	$ 33,288	33,288	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	273
Repurchase of common stock, including transaction costs	$ (1,152,287)	(276,035)	0	(876,252)
Stock-based compensation expense	$ 83,654	83,654	0	0
Repurchase of common stock, including transaction costs, Shares	(7,306)
Ending Balance at Apr. 02, 2022	$ 4,553,218
Ending Balance, Shares at Apr. 02, 2022	106,303
Common Stocks, Including Additional Paid in Capital	$ 4,035,849
Accumulated Other Comprehensive Income (Loss), Net of Tax	5,232
Retained Earnings (Accumulated Deficit)	512,137
Net (loss) income	103,152	0	0	103,152
Other comprehensive income (loss)	(8,407)	0	(8,407)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (20,847)	(20,847)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	665
Issuance of common stock in connection with employee stock purchase plan	$ 30,169	30,169	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	345
Repurchase of common stock, including transaction costs	$ (862,200)	(331,406)	0	(530,794)
Stock-based compensation expense	$ 107,709	107,709	0	0
Repurchase of common stock, including transaction costs, Shares	(8,664)
Ending Balance at Apr. 01, 2023	$ 3,902,794
Ending Balance, Shares at Apr. 01, 2023	98,649
Common Stocks, Including Additional Paid in Capital	$ 3,821,474
Accumulated Other Comprehensive Income (Loss), Net of Tax	(3,175)
Retained Earnings (Accumulated Deficit)	84,495
Net (loss) income	(70,322)	0	0	(70,322)
Other comprehensive income (loss)	(1,922)	0	(1,922)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (25,787)	(25,787)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	629
Issuance of common stock in connection with employee stock purchase plan	$ 35,045	35,045	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	479
Repurchase of common stock, including transaction costs	$ (402,975)	(299,204)	0	(103,771)
Stock-based compensation expense	$ 119,539	$ 119,539	$ 0	$ 0
Repurchase of common stock, including transaction costs, Shares	(3,959)
Ending Balance at Mar. 30, 2024	$ 3,556,372
Ending Balance, Shares at Mar. 30, 2024	95,798
Common Stocks, Including Additional Paid in Capital	$ 3,651,067
Accumulated Other Comprehensive Income (Loss), Net of Tax	(5,097)
Retained Earnings (Accumulated Deficit)	$ (89,598)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Cash flows from operating activities:
Net (loss) income	$ (70,322)	$ 103,152	$ 1,033,353
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation	193,035	206,423	210,949
Intangible assets amortization	127,898	132,425	150,466
Deferred income taxes	19,405	(66,145)	31,875
Asset impairments	36,715	227,101	0
Goodwill impairment	221,414	12,411	48,000
Stock-based compensation expense	120,834	105,580	83,507
Loss on classification as held for sale	35,262	0	0
Other, net	6,544	25,299	14,894
Changes in operating assets and liabilities:
Accounts receivable, net	(105,776)	264,781	(107,896)
Inventories	92,909	(81,450)	(236,196)
Prepaid expenses and other assets	(23,174)	43,240	(176,742)
Accounts payable	89,139	(115,495)	33,950
Accrued liabilities	130,979	(17,613)	(11,815)
Income taxes payable and receivable	8,681	(33,240)	(3,139)
Other liabilities	(50,354)	36,762	(21,963)
Net cash provided by operating activities	833,189	843,231	1,049,243
Investing activities:
Purchases of property and equipment	(127,230)	(158,953)	(213,466)
Proceeds from sales of property and equipment	49,548	1,847	898
Purchases of businesses, net of cash acquired	(82,974)	(95)	(389,136)
Other investing activities	24,186	3,792	5,748
Net cash used in investing activities	(136,470)	(153,409)	(595,956)
Financing activities:
Repurchase and payment of debt	(58,309)	0	(197,500)
Proceeds from borrowings and debt issuances (Note 9)	0	0	499,070
Repurchase of common stock, including transaction costs	(400,054)	(861,751)	(1,152,287)
Proceeds from the issuance of common stock	36,918	32,507	38,303
Tax withholding paid on behalf of employees for restricted stock units	(27,111)	(23,415)	(53,382)
Other financing activities	(11,018)	(694)	(9,714)
Net cash used in financing activities	(459,574)	(853,353)	(875,510)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	3,170	(331)	(3,281)
Net increase (decrease) in cash, cash equivalents and restricted cash	240,315	(163,862)	(425,504)
Cash, cash equivalents and restricted cash at the beginning of the period	808,943	972,805	1,398,309
Cash, cash equivalents and restricted cash at the end of the period	1,049,258	808,943	972,805
Cash and Cash Equivalents, at Carrying Value	1,029,258	808,757	972,592
Restricted Cash	20,000	186	213
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	1,049,258	808,943	972,805
Interest Paid, Excluding Capitalized Interest, Operating Activities	55,270	66,115	59,393
Income Taxes Paid, Net	103,059	105,788	125,322
Capital Expenditures Incurred but Not yet Paid	$ 70,127	$ 33,107	$ 36,069

The Company and Its Significant

The Company and Its Significant Accounting Policies	12 Months Ended
	Mar. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies	THE COMPANY AND ITS SIGNIFICANT ACCOUNTING POLICIES Qorvo, Inc. ("the Company" or "Qorvo") is a global leader in the development and commercialization of technologies and products for wireless, wired and power markets. Qorvo was formed as the result of a business combination (the "Business Combination") of RF Micro Devices, Inc. and TriQuint Semiconductor, Inc. ("TriQuint"), which closed on January 1, 2015. The Company's design expertise and manufacturing capabilities span multiple process technologies. In fiscal 2024, the Company's primary wafer fabrication facilities were in North Carolina, Oregon and Texas, and its primary assembly and test facilities were in China, Costa Rica, Germany and Texas. The Company also sources products and materials through external suppliers. The Company operates design, sales and other manufacturing facilities throughout Asia, Europe and North America. The Company is organized into three operating and reportable segments that align technologies and applications with customers and end markets: High Performance Analog ("HPA"), Connectivity and Sensors Group ("CSG") and Advanced Cellular Group ("ACG"). Principles of Consolidation and Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the fiscal 2024 presentation. Accounting Periods The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on March 30, 2024, April 1, 2023 and April 2, 2022. Fiscal years 2024, 2023, and 2022 were 52-week years. Use of Estimates The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent liabilities. The Company evaluates its estimates on an ongoing basis, including those related to revenue recognition, product warranty obligations, valuation of inventories, tax-related contingencies, valuation of long-lived and intangible assets, other contingencies and litigation, among others. The Company generally bases its estimates on historical experience, expected future conditions and third-party evaluations. Actual results could differ materially from these estimates, and such differences could affect the operations reported in future periods. Cash and Cash Equivalents Cash and cash equivalents consist of demand deposit accounts, money market funds and other short-term, highly liquid investments with original maturities of three months or less when purchased. Investments Marketable equity securities consist of common stock in publicly traded companies and are carried at fair value with both the realized and unrealized gains and losses reported in "Other income, net" in the Consolidated Statements of Operations. Fair values of publicly traded equity securities are determined using quoted prices in active markets. The marketable equity securities are classified as short-term based on their highly liquid nature and are recorded in "Other current assets" in the Consolidated Balance Sheets. The Company invests in limited partnerships which are accounted for using the equity method. These equity method investments are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company records its share of the financial results of the limited partnerships in "Other income, net" in the Company's Consolidated Statements of Operations. The Company also invests in privately held companies for which the fair value of the investment is not readily determinable. These equity investments without a readily determinable fair value are measured at cost less impairment, adjusted for any changes in observable prices and are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company assesses these investments for impairment on a quarterly basis and considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include the investee's financial condition and business outlook, market for technology and other relevant events and factors affecting the investee. Investments are impaired when their fair value is less than their carrying value. Fair Value Measurement The Company measures and reports certain financial assets and liabilities on a recurring basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is described as follows: • Level 1 - includes instruments for which inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. • Level 2 - includes instruments for which the inputs are other than quoted prices that are observable for the asset or liability, either directly or indirectly. • Level 3 - includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. These inputs are supported by little or no market activity and reflect the use of significant management judgment. The Company also holds assets whose fair value is measured and recorded on a nonrecurring basis. These assets include equity method investments, equity investments without a readily determinable fair value and certain non-financial assets, such as intangible assets and property and equipment. Goodwill and intangible assets are adjusted to fair value after initial recognition only if an impairment charge is recognized, which is generally determined using a discounted cash flow model based on significant unobservable inputs (Level 3). During fiscal 2024, in connection with the acquisition of Anokiwave, Inc. ("Anokiwave"), the Company recorded intangible assets, which were recognized at fair value (refer to Note 6 for additional information). The fair value of these intangible assets was determined utilizing significant unobservable input assumptions (Level 3). During fiscal 2024, in connection with the Company’s agreement to divest its assembly and test operations in Beijing and Dezhou, China (the “Disposal Group”), the Company measured the Disposal Group at the lower of its carrying value or fair value less costs to sell (refer to Note 4 for additional information). The fair value of these assets was determined utilizing significant unobservable inputs (Level 3). The carrying values of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments. Inventories Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). Cost includes labor, materials and manufacturing overhead related to the purchase and production of inventories. In accordance with Accounting Standards Codification ("ASC") 330, "Inventory" , abnormal manufacturing costs are charged to "Cost of goods sold" in the Consolidated Statements of Operations in the period incurred rather than as a portion of inventory cost. The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against demand forecasts on a material or product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of demand forecasts and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold is recorded at the full inventory cost, net of the reserve. Product Warranty The Company generally sells products with a limited warranty against defects in materials and workmanship and non-conformance to applicable specifications. The majority of the Company’s product warranty claims are settled through the return of the defective product and the shipment of replacement product. Accruals are estimated based upon both historical experience as well as specifically identified claims. If there is a significant increase in the rate of customer claims compared with the Company's historical experience or if the Company's estimates of probable losses relating to specifically identified warranty exposures require revision, the Company may record a charge against future cost of sales. Product warranty accruals and related expenses were immaterial for the periods presented. Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets. The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held and used by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as "held for sale" are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment of those assets, if any, is based on the excess of the carrying amount over the fair value less costs to sell. Leases The Company determines that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists, the Company assesses whether it has the right to direct the use of the identified asset and obtain substantially all of the economic benefit from the use of the identified asset. Right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate in determining the present value of lease payments considering the term of the lease, which is derived from information available at the lease commencement date. The lease term includes options to extend or terminate the lease when it is reasonably certain such options will be exercised. To the extent that the Company's agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. The Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude from the balance sheet leases with an initial term of 12 months or less. The Company assesses right-of-use assets for impairment in accordance with its long-lived asset impairment policy. Business Acquisitions The Company allocates the fair value of the purchase price to the assets acquired and liabilities assumed based on their estimated fair value. The excess of the purchase price over the fair values of the identifiable assets and liabilities is recorded to goodwill. Goodwill is assigned to the Company's reporting unit that is expected to benefit from the synergies of the business combination. A number of assumptions, estimates and judgments are used in determining the fair value of acquired assets and liabilities, particularly with respect to the intangible assets acquired. The valuation of intangible assets requires the Company to use valuation techniques such as the income approach. The income approach includes management’s estimation of future cash flows (including expected revenue growth rates and profitability), the underlying product or technology life cycles and the discount rates applied to future cash flows. Judgment is also required in estimating the fair values of deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date, as well as inventory, property and equipment, pre-existing liabilities or legal claims, deferred revenue and contingent consideration, each as may be applicable. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. After the measurement period, any purchase price adjustments are recognized in the Consolidated Statements of Operations. Goodwill Impairment Testing In accordance with ASC 350, " Intangibles - Goodwill and Other " ("ASC 350"), goodwill is not amortized, but rather is reviewed for impairment at the reporting unit level on the first day of the Company's fourth quarter of each fiscal year, or when there is evidence that events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. Under ASC 350, the Company has the option to first assess qualitatively whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. In performing qualitative assessments, the Company considers the following factors which could trigger a goodwill impairment review: (i) significant underperformance relative to historical or projected future operating results; (ii) significant changes in the manner or use of the acquired assets or the strategy for the Company's overall business; (iii) significant negative industry or economic trends; (iv) a significant decline in the Company's stock price for a sustained period; and (v) a significant change in the Company's market capitalization relative to its net book value. If qualitative assessments conclude that it is more likely than not that the fair value of any reporting unit is less than its carrying value, quantitative assessments are performed on the applicable reporting units. The quantitative assessments consider both the income and market approaches to estimate the fair value of a reporting unit. The income approach is based on the discounted cash flow method that uses estimates of the reporting unit's revenue growth rates and operating margins as part of the Company's long-term planning process, taking into consideration historical data and industry and market conditions. The discount rate used to determine the present value of future cash flows is based on the weighted-average cost of capital adjusted for the relevant risk associated with business-specific characteristics and the uncertainty related to the ability to execute on the projected cash flows. The market approach estimates fair value based on market multiples of revenue and earnings derived from comparable publicly traded companies with similar operating and investment characteristics. Refer to Note 7 for additional information regarding goodwill and intangible asset impairment testing. Identified Intangible Assets The Company amortizes definite-lived intangible assets (including developed technology, customer relationships, technology licenses and trade names) on a straight-line basis over their estimated useful lives. In-process research and development ("IPRD") assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of the acquisition and are initially not subject to amortization. Upon completion of development, IPRD assets are transferred to developed technology and are amortized over their useful lives. The asset balances relating to abandoned projects are impaired and expensed to R&D. The Company evaluates definite-lived intangible assets for impairment in accordance with ASC 360-10-35, " Impairment or Disposal of Long-Lived Assets " to determine whether facts and circumstances (including external factors such as industry and economic trends and internal factors such as changes in the Company’s business strategy and forecasts) indicate that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amounts over the fair value of those assets and are recognized in the period in which the impairment determination was made. Revenue Recognition The Company generates revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, or at completion of a consignment process. Revenue is recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. A majority of the Company's revenue is recognized at a point in time, either on shipment or delivery of the product, depending on individual customer terms and conditions. Revenue from sales to the Company’s distributors is recognized upon shipment of the product to the distributors (sell-in). Revenue is recognized from the Company’s consignment programs at a point in time when the products are pulled from consignment inventory by the customer. Revenue recognized for products and services over time is approximately 4% of overall revenue. The Company applies a five-step approach as defined in ASC 606, " Revenue from Contracts with Customers, " in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations in the contract; and (5) recognizing revenue when the corresponding performance obligation is satisfied. Sales agreements are in place with certain customers and contain terms and conditions with respect to payment, delivery, warranty and supply, but typically do not require minimum purchase commitments. In the absence of a sales agreement, the Company’s standard terms and conditions apply. The Company considers a customer's purchase order, which is governed by a sales agreement or the Company’s standard terms and conditions, to be the contract with the customer. The Company’s pricing terms are negotiated independently on a stand-alone basis. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. Variable consideration in the form of rebate programs is offered to certain customers, including distributors, and represents less than 10% of net revenue in fiscal 2024. The Company determines variable consideration by estimating the most likely amount of consideration it expects to receive from the customer. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company may authorize sales returns under certain circumstances, which include courtesy returns and like-kind exchanges. The Company reduces revenue and records reserves for product returns and allowances, rebate programs and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement. The Company’s accounts receivable balance is from contracts with customers and represents the Company’s unconditional right to receive consideration from its customers. Payments are due upon completion of the performance obligation and subsequent invoicing. Substantially all payments are collected within the Company’s standard terms, which do not include any financing components. There have been no material impairment losses on accounts receivable for fiscal years 2024, 2023 or 2022. Contract assets and contract liabilities recorded on the Consolidated Balance Sheets were immaterial as of March 30, 2024 and April 1, 2023. The Company invoices customers upon shipment and recognizes revenue in accordance with delivery terms. As of March 30, 2024, the Company had $76.9 million in remaining unsatisfied performance obligations with an original duration greater than one year, of which the majority is expected to be recognized as income over the next 12 months. The Company includes shipping charges billed to customers in "Revenue" and includes the related shipping costs in "Cost of goods sold" in the Consolidated Statements of Operations. Taxes assessed by government authorities on revenue-producing transactions, including tariffs, value-added taxes and excise taxes, are excluded from revenue in the Consolidated Statements of Operations. The Company incurs commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded in the "Selling, general and administrative" expense line item in the Consolidated Statements of Operations) are expensed when incurred because such commissions are not owed until the performance obligation is satisfied, which coincides with the end of the contract term, and therefore, no remaining period exists over which to amortize the commissions. Research and Development The Company charges all R&D costs to expense as incurred. Income Taxes The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized. A more-likely-than-not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense. In accordance with ASC 740, " Income Taxes, " the Company recognizes a deferred tax liability for income taxes on unremitted foreign earnings of foreign subsidiaries which the Company intends to repatriate. If the Company asserts that such earnings will be permanently reinvested, a deferred tax liability is not recognized related to such earnings. It is the Company’s intent to repatriate all previously taxed earnings of foreign subsidiaries from outside the U.S. Stock-Based Compensation In accordance with ASC 718, " Compensation – Stock Compensation " ("ASC 718"), stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. As of March 30, 2024, total remaining unearned compensation cost related to unvested restricted stock units was $159.4 million, which will be amortized over the weighted-average remaining service period of approximately 1.4 years. Foreign Currency Translation The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with ASC 830, " Foreign Currency Matters. " The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenue and expenses are translated using the weighted-average exchange rates throughout the year. Translation adjustments are shown separately as a component of "Accumulated other comprehensive loss" within "Stockholders’ equity" in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in "Other income, net" in the Consolidated Statements of Operations. Supplemental Financial Information The "Accrued liabilities" balance as of March 30, 2024 includes accrued compensation and benefits of $116.0 million and accrued rebates of $106.9 million. The "Accrued liabilities" balance as of April 1, 2023 includes accrued compensation and benefits of $92.9 million and accrued rebates of $42.8 million. The "Other current liabilities" balance as of March 30, 2024 includes income taxes payable of $59.9 million. The "Other current liabilities" balances as of April 1, 2023 includes income taxes payable of $63.6 million and contingent consideration related to the acquisition of United Silicon Carbide, Inc. ("United SiC") of $31.3 million, which was paid in fiscal 2024. "Other income, net" includes $38.3 million, $21.1 million and $2.7 million of interest income in fiscal years 2024, 2023 and 2022, respectively. Recent Accounting Pronouncements and Other Developments In August 2022, the Creating Helpful Incentives to Produce Semiconductors and Science Act (the "CHIPS Act") was signed into law. The CHIPS Act provides for a 25% refundable tax credit on certain investments in domestic semiconductor manufacturing. The credit is provided for qualifying property, which is placed in service after December 31, 2022. The CHIPS Act also provides for certain other financial incentives to further investments in domestic semiconductor manufacturing. The Company is evaluating the provisions of the law and its potential impact to the Company.

Concentrations of Credit Risk

Concentrations of Credit Risk	12 Months Ended
	Mar. 30, 2024
Risks and Uncertainties [Abstract]
CONCENTRATIONS OF CREDIT RISK	CONCENTRATIONS OF CREDIT RISK The Company’s principal financial instrument subject to potential concentration of credit risk is accounts receivable, which is unsecured. The Company provides an allowance for doubtful accounts equal to estimated losses expected to be incurred in the collection of accounts receivable. The Company's trade receivables are evaluated on a collective (pool) basis and aggregated on the basis of similar risk characteristics, adjusting for broad-based economic indicators as well as customer specific factors. The Company has adopted credit policies and standards intended to accommodate industry growth and inherent risk and believes that credit risks are moderated by the financial stability of its major customers, conservative payment terms and the Company’s strict credit policies. The Company provides products to its largest end customer, Apple Inc., through sales to multiple contract manufacturers, which in the aggregate accounted for approximately 46%, 37% and 33% of total revenue in fiscal years 2024, 2023 and 2022, respectively. Samsung Electronics Co., Ltd., accounted for approximately 12%, 12% and 11% of total revenue in fiscal years 2024, 2023 and 2022, respectively. These customers primarily purchase radio frequency ("RF") solutions for a variety of mobile devices from the Company's ACG segment. The Company's three largest accounts receivable balances comprised approximately 60% and 54% of aggregate gross accounts receivable as of March 30, 2024 and April 1, 2023, respectively.

Inventories

Inventories	12 Months Ended
	Mar. 30, 2024
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES The components of inventories, net of reserves, are as follows (in thousands): March 30, 2024 April 1, 2023 Raw materials $ 201,748 $ 264,367 Work in process 347,175 345,545 Finished goods 161,632 186,684 Total inventories $ 710,555 $ 796,596

Business Held For Sale

Business Held For Sale	12 Months Ended
	Mar. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure	BUSINESS HELD FOR SALE On December 16, 2023, the Company entered into a definitive agreement with Luxshare Precision Industry Co., Ltd. ("Luxshare") to divest its assembly and test operations in Beijing and Dezhou, China for cash proceeds of approximately $240.0 million. In the fourth quarter of fiscal 2024, regulatory approvals were received, and the Disposal Group met the criteria to be classified as held for sale in accordance with ASC 360, " Property, Plant and Equipment " ("ASC 360"). The divestiture of the Disposal Group did not meet the criteria to be reported as discontinued operations per ASC 205-20, " Presentation of Financial Statements: Discontinued Operations. " In connection with this transaction, which was completed on May 2, 2024, Luxshare is providing assembly and test services to the Company under a long-term supply agreement. In accordance with ASC 805, " Business Combinations, " the Disposal Group constitutes a business, and therefore, the Company allocated $22.0 million of goodwill from three of its reporting units to assets held for sale based on a relative fair value basis. These reporting units were evaluated for impairment subsequent to the allocation of goodwill to the Disposal Group and it was determined that the fair value of all reporting units was in excess of their carrying amounts. Additionally, in accordance with ASC 360, the Disposal Group was measured at the lower of carrying value or fair value (based on the preliminary purchase price) less costs to sell. As the carrying value of the Disposal Group exceeded the fair value less costs to sell, a loss of $35.3 million was recognized upon classification of the Disposal Group as held for sale, which is recorded in "Other operating expense" in the Consolidated Statement of Operations. The carrying value of the major classes of assets and liabilities classified as held for sale as of March 30, 2024 are as follows (in thousands): Property and equipment, net $ 133,425 Other assets 39,115 Goodwill 22,000 Loss on classification as held for sale (35,262) Total assets of disposal group held for sale $ 159,278 Accounts payable and accrued liabilities $ 67,495 Other liabilities 20,877 Total liabilities of disposal group held for sale $ 88,372

Property and Equipment

Property and Equipment	12 Months Ended
	Mar. 30, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	PROPERTY AND EQUIPMENT The components of property and equipment are as follows (in thousands): March 30, 2024 (1) April 1, 2023 Land $ 23,039 $ 25,842 Building and leasehold improvements 354,037 463,888 Machinery and equipment 2,091,268 2,430,307 Construction in progress 86,230 130,086 Total property and equipment, gross 2,554,574 3,050,123 Less accumulated depreciation (1,683,592) (1,900,317) Total property and equipment, net $ 870,982 $ 1,149,806 (1) Excludes $133.4 million of property and equipment, net which has been reclassified to "Assets of disposal group held for sale." Refer to Note 4 for additional information.

Business Acquisitions

Business Acquisitions	12 Months Ended
	Mar. 30, 2024
BUSINESS ACQUISITION DISCLOSURE [Abstract]
BUSINESS ACQUISITIONS	BUSINESS ACQUISITIONS During fiscal 2024, the Company completed the acquisition of Anokiwave. During fiscal 2022, the Company completed the acquisitions of United SiC and NextInput, Inc. ("NextInput"). The goodwill resulting from these acquisitions is attributed to synergies and other benefits that are generated from these transactions. The operating results of these companies, which were not material either individually or in the aggregate, have been included in the Company's consolidated financial statements as of the acquisition dates. As a result, pro forma results of operations for these acquisitions have not been presented. Anokiwave, Inc. On February 5, 2024, the Company acquired all the outstanding equity interests of Anokiwave, a leading supplier of high-performance beamforming and mixed signal integrated circuits ("ICs") enabling intelligent active array antennas for defense and aerospace, satellite communication and 5G applications, for a total purchase price of $93.7 million. The acquisition added high-frequency beamforming and intermediate frequency to RF conversion ICs to the Company's broad RF offerings enabling complete RF system solutions. The purchase price was preliminarily allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands): Intangible assets $ 47,700 Goodwill 16,140 Net tangible assets (1) 23,815 Deferred tax asset, net 6,030 Total purchase price $ 93,685 (1) Includes cash acquired of $10.7 million. The significant intangible assets acquired included developed technology of $34.0 million and customer relationships of $13.0 million . The fair value of the developed technology acquired was determined based on an income approach using the "excess earnings method" which estimated the value of the intangible asset by discounting the future projected earnings of the asset to present value as of the valuation date. The acquired developed technology asset is being amortized on a straight-line basis over its estimated useful life of seven years. The fair value of the customer relationships acquired was determined based on an income approach using the "with and without method" in which the value of the intangible asset is determined by the difference in discounted cash flows of the profitability of the Company "with" the asset and the profitability of the Company "without" the asset. These customer relationships are being amortized on a straight-line basis over the estimated useful life of two years. The Company will continue to evaluate certain assets, liabilities and tax estimates over the measurement period (up to one year from the acquisition date). Goodwill recognized from the acquisition of Anokiwave has been assigned to the HPA segment and is not deductible for income tax purposes. During fiscal 2024, the Company recorded acquisition and integration-related costs associated with the acquisition of Anokiwave totaling $6.4 million in "Other operating expense" in the Consolidated Statement of Operations. During fiscal 2024, the Company also recorded $1.3 million of acquisition and integration-related costs in "Cost of goods sold" in the Consolidated Statement of Operations. United Silicon Carbide, Inc. On October 19, 2021, the Company acquired all the outstanding equity interests of United SiC, a leading manufacturer of silicon carbide ("SiC") power semiconductors, for a total purchase price of $236.7 million. The acquisition expanded the Company's offerings to include SiC power products for a range of applications such as electric vehicles, battery charging, IT infrastructure, renewables and circuit protection. The purchase price comprised cash consideration of $227.2 million and contingent consideration of up to $31.3 million which was paid to the sellers during the first quarter of fiscal 2024 (in accordance with the terms of the acquisition agreement) due to the achievement of certain revenue and gross margin targets over the period beginning on the acquisition date through December 31, 2022. During fiscal years 2024, 2023 and 2022, the Company recorded acquisition and integration-related costs associated with the acquisition of United SiC totaling $0.9 million, $14.6 million and $12.2 million, respectively, in "Other operating expense" in the Consolidated Statements of Operations. During fiscal 2022, the Company also recorded $3.6 million of acquisition and integration-related costs in "Cost of goods sold" in the Consolidated Statement of Operations. NextInput, Inc. On April 5, 2021, the Company acquired all the outstanding equity interests of NextInput, a leader in microelectromechanical system ("MEMS")-based sensing solutions, for a total cash purchase price of $173.3 million. The acquisition expanded the Company's offerings of MEMS-based products for mobile applications, providing sensing solutions for a broad range of applications in other markets. In connection with the Company's fiscal 2022 annual qualitative goodwill impairment assessment, it was determined that the market adoption of the acquired NextInput technology into mobile handsets was expected to be delayed compared to the previous assumptions. As a result, the Company completed a quantitative assessment of its reporting unit, which resulted in a goodwill impairment charge of $48.0 million. Other Acquisitions

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Mar. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS The changes in the carrying amount of goodwill for fiscal 2024 are as follows (in thousands): HPA CSG ACG Total Balance as of April 1, 2023 (1) $ 501,602 $ 525,351 $ 1,733,860 $ 2,760,813 Goodwill impairment — (221,414) — (221,414) Goodwill resulting from Anokiwave acquisition (2) 16,140 — — 16,140 Effect of changes in foreign currency exchange rates — 1,062 — 1,062 Goodwill reclassified to "Assets of disposal group held for sale" (3) (200) (4,700) (17,100) (22,000) Balance as of March 30, 2024 (1) $ 517,542 $ 300,299 $ 1,716,760 $ 2,534,601 (1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $903.4 million and $682.0 million as of March 30, 2024 and April 1, 2023, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023 and 2024. (2) Refer to Note 6 for additional information. (3) Refer to Note 4 for additional information. The Company operates under three segments with a total of seven reporting units as of March 30, 2024. During fiscal 2024, the Company completed the sale of its non-core biotechnology business, which was a stand-alone reporting unit. During the second quarter of fiscal 2024, the Company completed an interim test for goodwill impairment as management determined, based on revisions to long-term forecasts, it was more likely than not that the fair value of a reporting unit within the CSG segment was below its carrying amount. The quantitative analysis, which considered the income approach and the market approach to estimate the reporting unit's fair value, resulted in a goodwill impairment charge of approximately $48.0 million. In the third quarter of fiscal 2024, the Company concluded that an impairment triggering event occurred for this same reporting unit as new information was received regarding slower than expected market adoption for one of CSG's new technologies and lower attach rates for a second CSG technology (resulting in further revisions to the long-term forecasts of this reporting unit). The Company concluded that it was more likely than not that the fair value of this reporting unit was below its carrying amount and a quantitative analysis was performed. The quantitative analysis, which considered the income approach and the market approach to estimate the reporting unit's fair value, resulted in a goodwill impairment charge of approximately $173.4 million. In fiscal 2023, the Company recorded a goodwill impairment charge of $12.4 million related to its biotechnology business. In fiscal 2022, the Company recorded a goodwill impairment charge of $48.0 million related to its NextInput business. The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): March 30, 2024 April 1, 2023 Gross Accumulated Gross Accumulated Developed technology $ 903,089 $ 484,347 $ 872,106 $ 382,448 Customer relationships 100,040 67,999 104,616 67,485 Technology licenses 54,869 6,525 1,664 513 Trade names 1,610 939 910 789 IPRD 9,585 N/A 9,642 N/A Total (1) $ 1,069,193 $ 559,810 $ 988,938 $ 451,235 (1) Amounts include the impact of foreign currency translation. At the beginning of each fiscal year, the Company removes the gross asset and accumulated amortization amounts of intangible assets that have reached the end of their useful lives and have been fully amortized. Useful lives are estimated based on the expected economic benefit to be derived from the intangible assets. In connection with completing the Company's fiscal 2024 goodwill impairment assessments, the Company also evaluated its long-lived intangible assets and determined that the forecasted undiscounted cash flows related to these assets were in excess of their carrying values. No definite-lived intangible asset impairment charges were recorded for fiscal years 2024, 2023 or 2022. Total intangible assets amortization expense was $127.9 million, $132.4 million and $150.5 million in fiscal years 2024, 2023 and 2022, respectively. The following table provides the Company's estimated amortization expense for intangible assets for the periods indicated (in thousands): Fiscal Year Estimated 2025 $ 134,000 2026 123,000 2027 99,000 2028 58,000 2029 36,000

Investments and Fair Value Meas

Investments and Fair Value Measurements	12 Months Ended
	Mar. 30, 2024
Investments and Fair Value Measurements [Abstract]
INVESTMENTS AND FAIR VALUE MEASUREMENTS	INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS Equity Method Investments The Company invests in limited partnerships and accounts for these investments using the equity method. The carrying amount of these investments as of March 30, 2024 and April 1, 2023 was $16.0 million and $20.4 million, respectively, and is classified as "Long-term investments" in the Consolidated Balance Sheets. During fiscal years 2024, 2023 and 2022, the Company recorded losses of $1.2 million and $4.2 million and income of $12.0 million, respectively, based on its share of the limited partnerships' earnings in "Other income, net" in the Consolidated Statements of Operations. The Company received cash distributions totaling $3.2 million, $2.5 million and $14.8 million during fiscal years 2024, 2023 and 2022, respectively. The cash distributions were recognized as reductions to the carrying value of the investments and included in the cash flows from investing activities in the Consolidated Statements of Cash Flows. Fair Value of Financial Instruments The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands): Total Quoted Prices In Significant Other Significant March 30, 2024 Marketable equity securities $ 84 $ 84 $ — $ — Invested funds in deferred compensation plan (1) 52,327 52,327 — — April 1, 2023 Marketable equity securities $ 1,094 $ 1,094 $ — $ — Invested funds in deferred compensation plan (1) 40,653 40,653 — — Contingent earn-out liability (2) (31,250) — — (31,250) (1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share as determined by quoted active market prices of the underlying investments. Refer to Note 11 for further information on the Company's non-qualified deferred compensation plan. (2) The fair value of the contingent consideration liability which related to the acquisition of United SiC (refer to Note 6) was equal to the maximum amount payable at April 1, 2023 and was subsequently paid in the first quarter of fiscal 2024.

Leases

Leases	12 Months Ended
	Mar. 30, 2024
Leases [Abstract]
Lessee, Operating Leases	LEASES The Company leases certain of its corporate, manufacturing and other facilities from multiple third-party real estate developers. The Company also leases various machinery and office equipment. These operating leases expire at various dates through 2034, and some of these leases have renewal options, with the longest ranging up to two, ten Operating leases are classified in the Consolidated Balance Sheets as follows (in thousands): March 30, 2024 April 1, 2023 Other non-current assets (1) $ 61,293 $ 83,490 Other current liabilities (2) 15,601 19,357 Other long-term liabilities (2) 50,578 69,156 (1) The March 30, 2024 balance excludes $17.3 million of right-of-use assets which have been reclassified to "Assets of disposal group held for sale." Refer to Note 4 for additional information. (2) The March 30, 2024 balances exclude $2.7 million and $12.7 million of current lease liabilities and long-term lease liabilities, respectively, which have been reclassified to "Liabilities of disposal group held for sale." Refer to Note 4 for additional information. Details of operating leases are as follows (in thousands): Fiscal Year 2024 2023 2022 Operating lease expense $ 21,531 $ 20,162 $ 19,178 Short-term lease expense 7,359 7,798 7,726 Variable lease expense 5,323 5,386 4,886 Cash paid for amounts included in the measurement of operating lease liabilities 22,471 21,480 20,536 Right-of-use assets obtained in exchange for new operating lease liabilities 11,750 28,940 29,210 The weighted-average remaining lease term and weighted-average discount rate for operating leases are as follows: March 30, 2024 April 1, 2023 Weighted-average remaining lease term (years) 6.3 6.5 Weighted-average discount rate 4.02 % 3.98 % The aggregate future lease payments for operating leases as of March 30, 2024 are as follows (in thousands): Fiscal Year Lease Payments (1) 2025 $ 17,185 2026 15,566 2027 11,945 2028 10,578 2029 5,840 Thereafter 13,335 Total future lease payments 74,449 Less imputed interest (8,270) Present value of lease liabilities $ 66,179 (1) Excludes future lease payments with a present value of $15.4 million which have been reclassified to "Liabilities of disposal group held for sale" on the Consolidated Balance Sheet. Refer to Note 4 for additional information.

Debt

Debt	12 Months Ended
	Mar. 30, 2024
Debt Disclosure [Abstract]
DEBT	DEBT The following table summarizes the outstanding debt (in thousands): March 30, 2024 April 1, 2023 1.750% senior notes due 2024 $ 439,738 $ 500,000 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Finance leases and other — 1,666 Unamortized premium, discount and issuance costs, net (1,726) (3,283) Total debt 1,988,012 2,048,383 Less current portion of debt (438,740) (310) Total long-term debt $ 1,549,272 $ 2,048,073 Credit Agreement On September 29, 2020, the Company and certain of its U.S. subsidiaries (the "Guarantors") entered into a five-year unsecured senior credit facility pursuant to a credit agreement (as amended, restated, modified or otherwise supplemented from time to time, the "2020 Credit Agreement") with Bank of America, N.A., acting as administrative agent and a syndicate of lenders. The 2020 Credit Agreement amended and restated the previous credit agreement dated as of December 5, 2017. The 2020 Credit Agreement included a senior revolving line of credit (the "2020 Revolving Facility") of up to $300.0 million and a senior term loan that was fully repaid in fiscal 2022. The 2020 Revolving Facility was available to finance working capital, capital expenditures and other general corporate purposes. On April 6, 2022, the Company and the administrative agent entered into an amendment to the 2020 Credit Agreement to replace the London Interbank Offered Rate as a reference rate available for use in the computation of interest under the 2020 Credit Agreement. On June 23, 2023, the Company entered into a second amendment to the 2020 Credit Agreement. The purpose of this amendment was to amend certain covenants related to the Company’s ratio of Consolidated Funded Indebtedness to Consolidated EBITDA, as such terms were defined in the 2020 Credit Agreement. This amendment increased such ratio to 4.00 to 1.00 for the fiscal quarters ended July 1, 2023 and September 30, 2023 and 3.50 to 1.00 for the fiscal quarters ended December 30, 2023 and March 30, 2024. During fiscal years 2024 and 2023, there were no borrowings under the 2020 Revolving Facility. The 2020 Credit Agreement contained various conditions, covenants and representations with which the Company had to be in compliance in order to borrow funds and to avoid an event of default. As of March 30, 2024, the Company was in compliance with these covenants. On April 23, 2024, the Company entered into a five-year unsecured senior credit facility pursuant to a credit agreement with Bank of America, N.A., as administrative agent, swing line lender and letter of credit issuer and a syndicate of lenders (the “2024 Credit Agreement”), which replaced the 2020 Credit Agreement. The 2024 Credit Agreement provides for a $325.0 million senior revolving line of credit (the “2024 Revolving Facility”). Up to $25.0 million of the 2024 Revolving Facility may be used for the issuance of standby letters of credit and up to $10.0 million of the 2024 Revolving Facility may be used for swing line advances (i.e., short-term borrowings made available from the lead lender). The Company may request at any time that the 2024 Revolving Facility be increased by up to $325.0 million , subject to securing additional funding commitments from existing or new lenders. The 2024 Revolving Facility is available to finance working capital, capital expenditures and other lawful corporate purposes. The initial maturity date of the 2024 Revolving Facility is April 23, 2029, which may be extended by up to two years by exercising extension options provided in the 2024 Credit Agreement. At the Company’s option, loans under the 2024 Credit Agreement will bear interest at (i) the Applicable Rate (as defined in the 2024 Credit Agreement) plus Term SOFR (as defined in the 2024 Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate of Bank of America, N.A., or (c) Term SOFR plus 1.00% (the “Base Rate”). All swing line loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. Term SOFR is the rate per annum equal to the forward-looking SOFR term rate for interest periods of one, three or six months, as selected by the Company, plus an adjustment of 0.10%. The Applicable Rate will be determined by reference to a pricing grid based on the Consolidated Leverage Ratio (as defined in the 2024 Credit Agreement) or, at the option of the Company, the Debt Rating (as defined in the 2024 Credit Agreement). The Applicable Rate for Term SOFR loans ranges from 1.000% per annum to 1.750% per annum and will initially be set at 1.250% per annum until the delivery of the Company’s first compliance certificate to the lenders. The Applicable Rate for Base Rate loans ranges from 0.000% per annum to 0.750% per annum and will initially be set at 0.250% per annum until the delivery of the Company’s first compliance certificate to the lenders. Undrawn amounts under the 2024 Revolving Facility are subject to a commitment fee ranging from 0.125% to 0.275%. Interest for Term SOFR loans will be payable at the end of each applicable interest period or at three-month intervals, if such interest period exceeds three months. Interest for Base Rate loans will be payable quarterly in arrears. The Company will pay a letter of credit fee equal to the Applicable Rate multiplied by the daily amount available to be drawn under any letter of credit, a fronting fee and any customary documentary and processing charges for any letter of credit issued under the 2024 Credit Agreement. The 2024 Credit Agreement contains various conditions, covenants and representations with which the Company must be in compliance in order to borrow funds and avoid an event of default, including a financial covenant that the Company must maintain a Consolidated Leverage Ratio not to exceed 3.50 to 1.00 as of the end of any fiscal quarter of the Company, provided that in connection with an acquisition in excess of $300.0 million , the Company’s maximum Consolidated Leverage Ratio may increase on two occasions during the term of the 2024 Revolving Facility to 4.00 to 1.00, in each case for four consecutive fiscal quarters, beginning with the fiscal quarter in which such acquisition occurs. Senior Notes due 2024 On December 14, 2021, the Company issued $500.0 million aggregate principal amount of its 1.750% senior notes due 2024 (the "2024 Notes"). The 2024 Notes will mature on December 15, 2024, unless earlier redeemed in accordance with their terms. The 2024 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The 2024 Notes were issued pursuant to an indenture, dated as of December 14, 2021 (the "2021 Indenture"), by and among the Company, the Guarantors and Computershare Trust Company, N.A., as trustee. The 2021 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events. The 2021 Indenture also contains customary negative covenants. In connection with the offering of the 2024 Notes, the Company agreed to provide the holders of the 2024 Notes with an opportunity to exchange the 2024 Notes for registered notes having terms substantially identical to the 2024 Notes. On November 24, 2023, the Company completed the exchange offer, in which substantially all the privately placed 2024 Notes were exchanged for new notes that have been registered under the Securities Act of 1933, as amended (the "Securities Act"). In fiscal 2024 , the Company repurchased $60.3 million of the principal amount of the 2024 Notes, plus accrued and unpaid interest, on the open market. The Company recognized a net gain on debt extinguishment of $1.8 million, which is included in "Other income, net" in the Consolidated Statement of Operations. The remaining principal amount of the 2024 Notes of $439.7 million is included in "Current portion of long-term debt" in the Consolidated Balance Sheet as of March 30, 2024. Interest is payable on the 2024 Notes on June 15 and December 15 of each year. Interest paid on the 2024 Notes during fiscal years 2024 and 2023 was $8.6 million and $8.8 million, respectively. Senior Notes due 2029 On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019 and June 11, 2020, the Company issued an additional $200.0 million and $300.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2029 Notes" and collectively with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to supplemental indentures, dated as of December 20, 2019 and June 11, 2020 (such indenture and supplemental indentures, collectively, the "2019 Indenture"). The 2019 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture. At any time prior to October 15, 2024, the Company may redeem all or part of the 2029 Notes, at a redemption price equal to 100% of their principal amount, plus a "make whole" premium as of the redemption date and accrued and unpaid interest. In addition, at any time prior to October 15, 2024, the Company may redeem up to 35% of the original aggregate principal amount of the 2029 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 104.375%, plus accrued and unpaid interest. Furthermore, at any time on or after October 15, 2024, the Company may redeem the 2029 Notes, in whole or in part, at the redemption prices specified in the 2019 Indenture, plus accrued and unpaid interest. Interest is payable on the 2029 Notes on April 15 and October 15 of each year. Interest paid on the 2029 Notes during each of the fiscal years 2024, 2023 and 2022 was $37.2 million. Senior Notes due 2031 On September 29, 2020, the Company issued $700.0 million aggregate principal amount of its 3.375% senior notes due 2031 (the "2031 Notes"). The 2031 Notes will mature on April 1, 2031, unless earlier redeemed in accordance with their terms. The 2031 Notes are senior unsecured obligations of the Company and are guaranteed, jointly and severally, by the Guarantors. The 2031 Notes were issued pursuant to an indenture, dated as of September 29, 2020, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee (the "2020 Indenture"). The 2020 Indenture contains substantially the same customary events of default and negative covenants as the 2021 Indenture. At any time prior to April 1, 2026, the Company may redeem all or part of the 2031 Notes, at a redemption price equal to 100% of their principal amount, plus a "make whole" premium as of the redemption date and accrued and unpaid interest. In addition, at any time prior to April 1, 2026, the Company may redeem up to 40% of the original aggregate principal amount of the 2031 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 103.375%, plus accrued and unpaid interest. Furthermore, at any time on or after April 1, 2026, the Company may redeem the 2031 Notes, in whole or in part, at the redemption prices specified in the 2020 Indenture, plus accrued and unpaid interest. The 2031 Notes have not been and will not be registered under the Securities Act, or any state securities laws, and may not be offered or sold in the United States absent an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. Interest is payable on the 2031 Notes on April 1 and October 1 of each year. Interest paid on the 2031 Notes during fiscal years 2024, 2023 and 2022 was $11.8 million, $23.6 million and $23.6 million, respectively. Fair Value of Debt The Company's debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of March 30, 2024 was $426.9 million, $797.6 million and $603.8 million, respectively (compared to the outstanding principal amount of $439.7 million, $850.0 million and $700.0 million, respectively). The estimated fair value of the 2024 Notes, the 2029 Notes and the 2031 Notes as of April 1, 2023 was $464.2 million, $785.9 million and $565.3 million, respectively (compared to the outstanding principal amount of $500.0 million, $850.0 million and $700.0 million, respectively). The Company considers its debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2024 Notes, the 2029 Notes and the 2031 Notes currently trade over-the-counter and the fair values were estimated based upon the value of the last trade at the end of the period. Interest Expense During fiscal 2024, the Company recognized $72.1 million of interest expense primarily related to the 2024 Notes, the 2029 Notes and the 2031 Notes, which was partially offset by $2.9 million of interest capitalized to property and equipment. During fiscal 2023, the Company recognized $72.3 million of interest expense primarily related to the 2024 Notes, 2029 Notes and the 2031 Notes, which was partially offset by $3.9 million of interest capitalized to property and equipment. During fiscal 2022, the Company recognized $67.0 million of interest expense primarily related to the 2029 Notes and the 2031 Notes, which was partially offset by $3.7 million of interest capitalized to property and equipment.

Retirement Benefit Plans

Retirement Benefit Plans	12 Months Ended
	Mar. 30, 2024
Retirement Benefits [Abstract]
RETIREMENT BENEFIT PLANS	RETIREMENT BENEFIT PLANS Defined Contribution Plans The Company offers tax-beneficial retirement contribution plans to eligible employees in the U.S. and certain other countries. Eligible employees in certain countries outside of the U.S. are eligible to participate in stakeholder, group or national pension plans with differing eligibility and contributory requirements based on local and national regulations. U.S. employees are eligible to participate in the Company's fully qualified 401(k) plan 30 days after their date of hire. An employee may contribute and invest pretax and/or Roth dollars into the 401(k) plan up to the maximum legal limits (as defined by Federal regulations). Employer contributions to the 401(k) plan are made at the discretion of the Company’s Board of Directors. Employees are immediately vested in their own contributions as well as employer matching contributions. In total, the Company contributed $20.3 million, $18.8 million and $17.6 million to its domestic and foreign defined contribution plans during fiscal years 2024, 2023 and 2022, respectively. Defined Benefit Pension Plans The Company maintains two qualified defined benefit pension plans for its subsidiaries located in Germany. One of the plans is funded through a self-paid reinsurance program with assets valued at $3.8 million as of March 30, 2024 and April 1, 2023 (included in "Other non-current assets" in the Consolidated Balance Sheets). The pension benefit obligations of both plans were $9.6 million and $9.4 million as of March 30, 2024 and April 1, 2023, respectively, which is included in "Accrued liabilities" and "Other long-term liabilities" in the Consolidated Balance Sheets. The benefit obligations for the plans are calculated annually by an independent actuary and require the use of significant judgment including assumptions based on local economic conditions. The net periodic benefit cost was approximately $0.5 million for fiscal years 2024 and 2023 and $0.6 million for fiscal 2022. Non-Qualified Deferred Compensation Plan

Commitments and Contingent Liab

Commitments and Contingent Liabilities	12 Months Ended
	Mar. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	COMMITMENTS AND CONTINGENT LIABILITIES Purchase Obligations As of March 30, 2024, the Company's purchase obligations (including capital commitments) totaled approximately $527.4 million, of which approximately $487.1 million is expected to be paid during fiscal 2025. In subsequent years, the Company expects to pay approximately $24.2 million, $11.7 million and $4.4 million related to these purchase obligations during fiscal years 2026, 2027 and 2028, respectively. Noncancelable purchase obligations represent payments due related to the purchase of materials, manufacturing services and property and equipment, a majority of which are not recorded as liabilities in the Consolidated Balance Sheet because the Company has not received the related goods or services as of March 30, 2024. In fiscal 2022, the Company entered into a long-term capacity reservation agreement with a foundry supplier to purchase a certain number of wafers through calendar year 2025. During fiscal 2023, the agreement was amended to extend the term through calendar year 2026, and the Company recorded total charges of $181.0 million to "Cost of goods sold" based on the actual and estimated purchase shortfalls. During fiscal 2024, the agreement was terminated effective December 31, 2023, and the Company is no longer obligated to order silicon wafers from the foundry supplier. Total charges of $38.4 million were recorded to "Cost of goods sold" in the fiscal 2024 Consolidated Statement of Operations, primarily due to a contract termination fee. Legal Matters The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of business that have not been fully adjudicated. The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company regularly evaluates developments in its legal matters that could affect the amount of the previously accrued liability and records adjustments as appropriate. Although it is not possible to predict with certainty the outcome of the unresolved legal matters, it is the opinion of management that these matters will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position or results of operations. The aggregate range of reasonably possible losses in excess of accrued liabilities, if any, associated with these unresolved legal matters is not material.

Restructuring

Restructuring	12 Months Ended
	Mar. 30, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING	RESTRUCTURING In the third quarter of fiscal 2024 the Company entered into a definitive agreement with Luxshare to divest its assembly and test operations in Beijing and Dezhou, China. The sale of these operations (the "2024 Restructuring Initiative") was completed on May 2, 2024 and will further enhance the Company's operational efficiencies and reduce capital intensity (refer to Note 4 for additional information). During fiscal 2025, the Company expects to incur additional charges associated with the 2024 Restructuring Initiative of approximately $5.0 million to $10.0 million, primarily related to employee termination benefits and legal and consulting fees. The following table summarizes fiscal 2024 charges resulting from the 2024 Restructuring Initiatives (in thousands): Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ — $ 7,213 $ 7,213 Asset impairment costs (1) 1,213 35,733 36,946 One-time employee termination benefits — 8,887 8,887 Total $ 1,213 $ 51,833 $ 53,046 (1) Refer to Note 4 for additional information. During fiscal 2023, the Company initiated actions to improve efficiencies in its operations and further align the organization with its strategic objectives. These initiatives (the "2023 Restructuring Initiatives") included seeking strategic alternatives related to its non-core biotechnology business. In fiscal 2024, the Company recognized a gain on the sale of its non-core biotechnology business, which is recorded in "Other operating expense" in the Consolidated Statement of Operations. As of March 30, 2024, the Company has incurred cumulative charges of $163.9 million related to the 2023 Restructuring Initiatives. The 2023 Restructuring Initiatives have been completed and the Company does not expect to incur additional charges. The following tables summarize, by fiscal year, the charges resulting from the 2023 Restructuring Initiatives (in thousands): Fiscal 2024 Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 19,028 $ 4,244 $ 23,272 Asset impairment costs 2,159 9,307 11,466 One-time employee termination benefits — 2,681 2,681 Total $ 21,187 $ 16,232 $ 37,419 Fiscal 2023 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ 3,600 $ — $ 19,183 $ 22,783 Asset impairment costs (1) 43,004 12,411 45,422 100,837 One-time employee termination benefits — — 2,885 2,885 Total $ 46,604 $ 12,411 $ 67,490 $ 126,505 (1) Refer to Note 7 for additional information. Asset impairment costs include inventory write-downs (for inventory expected to be disposed of) and equipment impairments (to adjust the carrying value of certain equipment to reflect its fair value). The estimated fair value of the equipment was determined using a market approach based upon quoted market prices from auction data. The significant inputs related to valuing these assets are classified as Level 2 in the fair value measurement hierarchy. The following table summarizes the activity related to the Company's restructuring liabilities for fiscal years 2023 and 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance, April 2, 2022 $ — $ — $ — Costs incurred and charged to expense 2,885 22,783 25,668 Cash payments (2,885) (17,535) (20,420) Accrued restructuring balance, April 1, 2023 $ — $ 5,248 $ 5,248 Costs incurred and charged to expense 11,568 32,785 44,353 Cash payments (3,789) (22,344) (26,133) Accrued restructuring balance, March 30, 2024 $ 7,779 $ 15,689 $ 23,468 The accrued restructuring balances as of March 30, 2024 represent estimated future cash payments required to satisfy the Company's remaining obligations, which are expected to be paid in the next twelve months.

Income Taxes

Income Taxes	12 Months Ended
	Mar. 30, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES Income (loss) before income taxes consists of the following components (in thousands): Fiscal Year 2024 2023 2022 United States $ (281,790) $ (466,070) $ 69,938 Foreign 355,350 590,699 1,111,146 Total $ 73,560 $ 124,629 $ 1,181,084 The components of the income tax provision are as follows (in thousands): Fiscal Year 2024 2023 2022 Current tax expense: Federal $ (36,155) $ (21,704) $ (16,886) State (232) (488) (274) Foreign (88,090) (65,430) (98,696) (124,477) (87,622) (115,856) Deferred tax (expense) benefit: Federal (6,532) 60,351 (18,398) State 1,090 2,371 (2,762) Foreign (13,963) 3,423 (10,715) (19,405) 66,145 (31,875) Total $ (143,882) $ (21,477) $ (147,731) A reconciliation of the provision for income taxes to income tax expense computed by applying the statutory federal income tax rate to pre-tax income for fiscal years 2024, 2023 and 2022 is as follows (dollars in thousands): Fiscal Year 2024 2023 2022 Amount Percentage Amount Percentage Amount Percentage Income tax expense at statutory federal rate $ (15,448) 21.0 % $ (26,172) 21.0 % $ (248,028) 21.0 % (Increase) decrease resulting from: State (expense) benefit, net of federal impact (1,028) 1.4 2,259 (1.8) (1,888) 0.2 Tax credits 67,726 (92.1) 97,809 (78.5) 118,877 (10.1) Effect of changes in income tax rate applied to net deferred tax assets (1) (150) 0.2 (950) 0.8 (25,679) 2.2 Foreign tax rate difference 46,102 (62.7) 73,491 (59.0) 148,932 (12.6) Foreign permanent differences and related items (5,540) 7.5 (10,852) 8.7 786 (0.1) Change in valuation allowance (7,537) 10.2 385 (0.3) 231 (0.1) Expiration of state and foreign attributes (1,947) 2.6 (1,962) 1.6 (3,048) 0.3 Stock-based compensation (10,696) 14.5 (9,036) 7.2 11,148 (0.9) Tax reserve adjustments (8,451) 11.5 (9,437) 7.6 (3,262) 0.3 U.S. tax on foreign earnings, including GILTI & FDII (2) (3) (129,692) 176.4 (128,708) 103.3 (130,874) 11.1 Tax on unremitted foreign earnings (3,283) 4.5 (402) 0.3 (1,033) 0.1 2024 Restructuring Initiative related adjustments (42,715) 58.1 — — — — Impairments and acquisition related adjustments (31,717) 43.2 (5,695) 4.5 (12,198) 1.0 Other income tax benefit (expense) 494 (0.7) (2,207) 1.8 (1,695) 0.1 $ (143,882) 195.6 % $ (21,477) 17.2 % $ (147,731) 12.5 % (1) In fiscal 2022, the Company negotiated an extension to its tax holiday in Singapore, resulting in the revaluation of its deferred tax assets. As a result, the Company recognized an income tax expense of $26.4 million due to the reduced tax rate. (2) The Global Intangible Low-Taxed Income ("GILTI") and Foreign-Derived Intangible Income ("FDII") provisions became effective for the Company in fiscal 2019, at which time the Company elected to treat taxes due on future GILTI inclusions in U.S. taxable income as a period cost. (3) Beginning in fiscal 2023 and as required by the Tax Cuts and Jobs Act, the Company was required to capitalize and amortize research and development expenses which were previously expensed for U.S. tax purposes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the basis used for income tax purposes. The deferred income tax assets and liabilities are measured in each taxing jurisdiction using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Significant components of the Company’s net deferred income taxes are as follows (in thousands): March 30, 2024 April 1, 2023 Deferred income tax assets: Capitalized research and development expenses $ 60,875 $ 13,794 Research and other tax credits 54,681 57,048 Employee benefits 28,225 30,309 Net operating loss carryforwards 25,563 22,189 Inventories 16,290 24,374 Lease liabilities 14,395 18,768 Deferred revenue 153 14,475 Prepaid expenses 9 17,360 Other 12,736 15,898 Total deferred income tax assets 212,927 214,215 Valuation allowance (43,636) (35,896) Total deferred income tax assets, net of valuation allowance $ 169,291 $ 178,319 Deferred income tax liabilities: Intangible assets $ (71,912) $ (69,050) Property and equipment (48,139) (39,806) Accrued tax on unremitted foreign earnings (40,912) (25,948) Right-of-use assets (13,301) (17,457) Other (3,834) (2,645) Total deferred income tax liabilities (178,098) (154,906) Net deferred income tax (liability) asset $ (8,807) $ 23,413 Amounts included in the Consolidated Balance Sheets: Other non-current assets $ 25,400 $ 38,060 Other long-term liabilities (34,207) (14,647) Net deferred income tax (liability) asset $ (8,807) $ 23,413 The Company has recorded a valuation allowance against certain U.S. and foreign deferred tax assets as of March 30, 2024 and April 1, 2023. These valuation allowances were established based upon management's opinion that it is more likely than not (a likelihood of more than 50 percent) that the benefit of these deferred tax assets will not be realized. The valuation allowance against deferred tax assets increased in fiscal 2024 by $7.7 million and decreased in fiscal years 2023 and 2022 by $0.4 million and $0.2 million, respectively. The components of the change in valuation allowances and ending balances are as follows (in thousands): Fiscal Year 2024 2023 2022 Beginning valuation allowance $ 35,896 $ 36,281 $ 36,512 Domestic net operating losses and credits (3,164) 583 1,339 Foreign net operating losses and other deferred tax assets 10,904 (968) (1,570) Ending valuation allowance $ 43,636 $ 35,896 $ 36,281 Components of ending valuation allowance: Domestic deferred tax assets $ 32,406 $ 35,570 $ 34,987 Foreign deferred tax assets 11,230 326 1,294 Valuation allowance $ 43,636 $ 35,896 $ 36,281 As of March 30, 2024, the Company had federal tax loss carryforwards of approximately $37.3 million, some of which expire in fiscal years 2025 to 2038, and state tax loss carryforwards of approximately $127.0 million that expire in fiscal years 2025 to 2044. Federal research credits of $89.5 million expire in fiscal years 2039 to 2044 and federal foreign tax credits of $8.9 million expire in fiscal 2034. A portion of the Company's state research credits of $70.0 million expire in fiscal years 2025 to 2039, while the remainder carry forward indefinitely. The Company had foreign tax loss carryforwards of $101.0 million, some of which expire in fiscal years 2025 to 2034. Each tax loss carryforward and tax credit expire only if unused prior to their respective expiration date. The utilization of acquired domestic tax assets is subject to certain annual limitations as required under Section 382 of the Internal Revenue Code of 1986, as amended, and similar state income tax provisions. The Company currently operates in numerous international jurisdictions, which expose the Company to taxation in various regions. The Company continually evaluates its global cash needs and has historically asserted that some of its unremitted earnings were permanently reinvested. During the third quarter of fiscal 2024, the Company entered into a definitive agreement to divest its assembly and test operations in China (refer to Note 4 for additional information), and it was determined the Company could no longer support its permanent reinvestment assertion on related, unremitted earnings. As a result, the Company is not permanently reinvested on earnings of its foreign subsidiaries which have been subject to U.S. federal taxation and has recognized a corresponding deferred tax liability for the estimated tax that would be incurred upon repatriation. The Company has foreign subsidiaries with tax holiday agreements in Costa Rica and Singapore. These tax holiday agreements have varying rates and expire in December 2027 and December 2031, respectively. Incentives from these countries are subject to the Company meeting certain employment and investment requirements. Relative to the statutory tax rate, income tax expense decreased by $57.2 million (an impact of approximately $0.59 per basic and diluted share) in fiscal 2024 and $65.5 million (an impact of approximately $0.64 per basic and diluted share) in fiscal 2023 as a result of these agreements. The Company’s gross unrecognized tax benefits totaled $158.9 million, $152.3 million and $144.1 million as of March 30, 2024, April 1, 2023 and April 2, 2022, respectively. Of these amounts, $152.6 million, $145.9 million and $137.5 million as of March 30, 2024, April 1, 2023 and April 2, 2022, respectively, represent the amounts of unrecognized tax benefits that, if recognized, would impact the effective tax rate in each of the fiscal years. The Company’s gross unrecognized tax benefits increased from $152.3 million as of April 1, 2023 to $158.9 million as of March 30, 2024, primarily due to current year tax positions, positions related to business combinations recognized as part of the purchase accounting and the effect of adjustments to prior year positions. A summary of the changes in the amount of gross unrecognized tax benefits is as follows (in thousands): Fiscal Year 2024 2023 2022 Beginning balance $ 152,331 $ 144,055 $ 134,068 Additions based on positions related to current year 5,298 9,718 11,826 Additions for tax positions in prior years 4,122 2,467 3,049 Reductions for tax positions in prior years (2,416) (363) (1,669) Expiration of statute of limitations (436) (3,546) (3,219) Ending balance $ 158,899 $ 152,331 $ 144,055 It is the Company’s policy to recognize interest and penalties related to uncertain tax positions as a component of income tax expense. During fiscal years 2024, 2023 and 2022, the Company recognized $3.5 million, $0.9 million and $(5.1) million, respectively, of interest and penalties related to uncertain tax positions. Accrued interest and penalties related to unrecognized tax benefits totaled $5.3 million, $1.9 million and $1.0 million as of March 30, 2024, April 1, 2023 and April 2, 2022, respectively. The unrecognized tax benefits of $158.9 million and accrued interest and penalties of $5.3 million at the end of fiscal 2024 are recorded on the Consolidated Balance Sheet as a $43.9 million other long-term liability, with the balance reducing the carrying value of the gross deferred tax assets. Due to uncertainties regarding the timing of examinations and the amount of settlements that may be paid, if any, to tax authorities, the Company believes it is reasonably possible that $24.9 million of gross unrecognized tax benefits will be reduced within the next 12 months. The Company files a consolidated U.S. federal income tax return, as well as separate and combined income tax returns in numerous state and international jurisdictions. The Company’s fiscal 2017 U.S. federal and state tax returns and subsequent tax years remain open for examination, as well as all attributes brought forward into those years. The Company is also subject to examination by various international tax authorities. The tax years subject to examination vary by jurisdiction.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
	Mar. 30, 2024
Earnings Per Share [Abstract]
NET INCOME (LOSS) PER SHARE	NET (LOSS) INCOME PER SHARE The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data): Fiscal Year 2024 2023 2022 Numerator: Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders $ (70,322) $ 103,152 $ 1,033,353 Denominator: Denominator for basic net (loss) income per share — weighted-average shares 97,557 102,206 110,196 Effect of dilutive securities: Stock-based awards — 813 1,350 Denominator for diluted net (loss) income per share — adjusted weighted-average shares and assumed conversions 97,557 103,019 111,546 Basic net (loss) income per share $ (0.72) $ 1.01 $ 9.38 Diluted net (loss) income per share $ (0.72) $ 1.00 $ 9.26 In the computation of net loss per share for fiscal 2024, approximately 1.5 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. In the computation of diluted net income per share for fiscal 2023, approximately 0.8 million shares of outstanding stock-based awards were excluded because the effect of their inclusion would have been anti-dilutive. An immaterial number of shares of outstanding stock-based awards were excluded from the computation of diluted net income per share for fiscal 2022 because the effect of their inclusion would have been anti-dilutive.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Mar. 30, 2024
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION Summary of Stock Plans 2009 and 2012 Incentive Plans – TriQuint Semiconductor, Inc. Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2009 Incentive Plan and the TriQuint, Inc. 2012 Incentive Plan (the "TriQuint Incentive Plans"), originally adopted by TriQuint. The TriQuint Incentive Plans provided for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates. No further awards can be granted under these plans. 2012 Stock Incentive Plan – Qorvo, Inc. The 2012 Stock Incentive Plan (the "2012 Plan") was assumed by the Company in connection with the Business Combination and reapproved by the Company's stockholders on August 8, 2017 for purposes of Section 162(m) of the Internal Revenue Code. Under the 2012 Plan, the Company was permitted to grant stock options and other types of equity incentive awards, such as stock appreciation rights, restricted stock awards, performance shares and performance units. No further awards can be granted under this plan. 2013 Incentive Plan – Qorvo, Inc. Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2013 Incentive Plan (the "2013 Incentive Plan"), originally adopted by TriQuint, allowing the Company to issue awards under this plan. The 2013 Incentive Plan replaced the TriQuint 2012 Incentive Plan and provided for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates who were such prior to the Business Combination or who became employed by the Company or its affiliates after the closing of the Business Combination. No further awards can be granted under this plan. 2022 Stock Incentive Plan – Qorvo, Inc. The Company currently grants equity-based awards to eligible employees, directors and independent contractors under the 2022 Stock Incentive Plan (the "2022 Plan"), which was approved by the Company's stockholders on August 9, 2022. Under the 2022 Plan, the Company is permitted to grant awards, such as restricted stock units, restricted stock awards, performance shares, performance units, stock options, stock appreciation rights and phantom stock awards, to eligible participants. The maximum number of shares issuable under the 2022 Plan may not exceed 4.5 million shares (subject to adjustment for anti-dilution purposes). The aggregate number of shares subject to performance-based restricted stock units earned in fiscal 2024 under the 2022 Plan was 0.2 million shares. As of March 30, 2024, approximately 3.1 million shares were available for issuance under the 2022 Plan. Employee Stock Purchase Plan – Qorvo, Inc. Effective upon closing of the Business Combination, the Company assumed the TriQuint Employee Stock Purchase Plan (the "ESPP"), which is intended to qualify as an "employee stock purchase plan" under Section 423 of the Internal Revenue Code. All regular full-time employees of the Company (including officers) and all other employees who meet the eligibility requirements of the plan may participate in the ESPP. The ESPP provides eligible employees an opportunity to acquire the Company’s common stock at 85.0% of the lower of the closing price per share of the Company’s common stock on the first or last day of each six-month purchase period. As of March 30, 2024, 2.2 million shares were available for future issuance under this plan. The Company makes no cash contributions to the ESPP but bears the expenses of its administration. The Company issued 0.5 million shares under the ESPP in fiscal 2024 and 0.3 million shares in fiscal years 2023 and 2022. For fiscal years 2024, 2023 and 2022, the primary stock-based awards and their general terms and conditions are as follows: Restricted stock units granted by the Company in fiscal years 2024, 2023 and 2022 are either service-based or performance and service-based. Service-based restricted stock units generally vest over a four two The restricted stock units granted to certain officers of the Company generally will, in the event of the officer's termination other than for cause and subject to the officer executing certain agreements in favor of the Company, continue to vest pursuant to the same vesting schedule as if the officer had remained an employee of the Company and, as a result, these awards are expensed at grant date. In fiscal 2024, stock-based compensation of $34.7 million was recognized upon the grant of 0.4 million restricted share units to certain officers of the Company. Stock-Based Compensation Under ASC 718, stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units and is recognized as expense over the employee's requisite service period. ASC 718 covers a wide range of stock-based compensation arrangements including stock options, restricted share plans, performance-based awards, share appreciation rights and employee stock purchase plans. Total pre-tax stock-based compensation expense recognized in the Consolidated Statements of Operations was $120.8 million, $105.6 million and $83.5 million, for fiscal years 2024, 2023 and 2022, respectively, net of expense capitalized into inventory. A summary of activity with respect to stock options under the Company’s director and employee stock plans follows: Options Weighted- Weighted-Average Remaining Contractual Term (in years) Aggregate Outstanding as of April 1, 2023 69 $ 20.95 Granted — — Exercised (66) $ 20.13 Canceled (2) $ 15.47 Forfeited — — Outstanding as of March 30, 2024 1 $ 67.84 0.83 $ 65 Vested and expected to vest as of March 30, 2024 1 $ 67.84 0.83 $ 65 Options exercisable as of March 30, 2024 1 $ 67.84 0.83 $ 65 The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based upon the Company’s closing stock price of $114.83 as of March 28, 2024 (the last Nasdaq trading day prior to the end of fiscal 2024), that would have been received by the option holders had all option holders with in-the-money options exercised their options as of that date. As of March 30, 2024, there was no remaining unearned compensation cost related to unvested option awards. The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model based on the historical volatility, dividend yield, term and risk-free interest rate. There were no options granted during fiscal years 2024, 2023 and 2022. The total intrinsic value of options exercised during fiscal years 2024, 2023 and 2022 was $5.1 million, $16.5 million and $27.1 million, respectively. Cash received from the exercise of stock options and from participation in the employee stock purchase plan (excluding accrued unremitted employee funds) was approximately $36.4 million for fiscal 2024 and is reflected in cash flows from financing activities in the Consolidated Statement of Cash Flows. The Company settles employee stock options with newly issued shares of the Company's common stock. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based upon historical pre-vesting forfeiture experience, the Company assumed an annualized forfeiture rate of 1.4% for both stock options and restricted stock units. A summary of activity with respect to restricted stock units ( " RSUs " ) under the Company’s director and employee stock plans follows: RSUs Weighted-Average Unvested balance as of April 1, 2023 1,832 $ 118.38 Granted 1,340 102.14 Vested (830) 112.19 Forfeited (118) 115.85 Unvested balance as of March 30, 2024 2,224 $ 111.32 As of March 30, 2024, total remaining unearned compensation cost related to unvested restricted stock units was $159.4 million, which will be amortized over the weighted-average remaining service period of approximately 1.4 years. The total intrinsic value of restricted stock units that vested during fiscal years 2024, 2023 and 2022 was $85.8 million, $74.1 million and $163.6 million, respectively, based upon the fair market value of the Company’s common stock on the vesting date. The Company settles restricted stock units with newly issued shares of the Company's common stock.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Mar. 30, 2024
Equity [Abstract]
SHAREHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Stock Repurchase On November 2, 2022, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $2.0 billion of the Company's outstanding common stock, which included the remaining authorized dollar amount under a prior program terminated concurrent with the new authorization. Under the current program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice. As of January 1, 2023, the Company's share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. The excise tax is recognized as part of the cost basis of shares acquired in the Consolidated Statements of Stockholders' Equity. During fiscal years 2024, 2023 and 2022, the Company repurchased approximately 4.0 million shares, 8.7 million shares and 7.3 million shares of its common stock, respectively, for approximately $403.0 million, $862.2 million and $1,152.3 million, respectively (including transaction costs and excise tax, as applicable) under the prior and current share repurchase programs. As of March 30, 2024, approximately $1,305.0 million remains authorized for repurchases under the current share repurchase program. Common Stock Reserved For Future Issuance As of March 30, 2024, the Company had reserved a total of approximately 7.5 million of its authorized 405.0 million shares of common stock for possible future issuance as follows (in thousands): Company stock incentive plans 3,088 Employee stock purchase plan 2,160 Unvested restricted stock units 2,224 Total shares reserved 7,472

Operating Segment and Geographi

Operating Segment and Geographical Information	12 Months Ended
	Mar. 30, 2024
Segment Reporting [Abstract]
OPERATING SEGMENT AND GEOGRAPHIC INFORMATION	OPERATING SEGMENT AND GEOGRAPHIC INFORMATION The Company's three operating and reportable segments are based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is also the Company's chief operating decision maker ("CODM"). The CODM allocates resources and evaluates the performance of each of the three operating segments primarily based on operating income. The Company’s manufacturing facilities service and provide benefit to all three operating segments and the operating costs of the facilities are reflected in the cost of goods sold of each operating segment. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from investments, interest expense, other income (expense), or taxes to operating segments. The CODM does not evaluate operating segments using discrete asset information. HPA is a leading global supplier of RF, analog mixed signal and power management solutions. HPA leverages a diverse portfolio of differentiated technologies and products to support multiyear growth trends, including electrification, renewable energy, the increasing semiconductor spend in defense and aerospace and 5G and 6G network infrastructure. CSG is a leading global supplier of connectivity and sensor solutions, with broad expertise spanning ultra-wideband, Matter ® , Bluetooth ® Low Energy, Zigbee ® , Thread ® , Wi-Fi ® , cellular Internet of Things and MEMS-based sensors. CSG’s markets include home and consumer electronics, industrial automation, automotive, smartphones, wearables, and industrial and enterprise access points. ACG is a leading global supplier of cellular RF solutions for smartphones, wearables, laptops, tablets and other devices. ACG leverages world-class technology and systems-level expertise to deliver a broad portfolio of high-performance cellular products to the world's leading smartphone and consumer electronics companies. The "All other" category includes operating expenses such as stock-based compensation expense, amortization of intangible assets, restructuring-related charges, acquisition and integration-related costs, goodwill impairment, charges associated with a long-term capacity reservation agreement, gain or loss on disposal of business and assets and other miscellaneous corporate overhead expenses that the Company does not allocate to its operating segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. Except as discussed above regarding the "All other" category, the Company's accounting policies for segment reporting are the same as for the Company as a whole. The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Fiscal Year 2024 2023 2022 Revenue: HPA $ 572,953 $ 727,187 $ 707,395 CSG 434,537 474,364 703,881 ACG 2,762,016 2,367,848 3,234,438 Total revenue $ 3,769,506 $ 3,569,399 $ 4,645,714 Operating income (loss): HPA $ 82,501 $ 198,820 $ 210,441 CSG (88,649) (72,080) 107,814 ACG 727,906 627,708 1,233,388 All other (630,057) (571,280) (325,574) Operating income 91,701 183,168 1,226,069 Interest expense (69,245) (68,463) (63,326) Other income, net 51,104 9,924 18,341 Income before income taxes $ 73,560 $ 124,629 $ 1,181,084 Fiscal Year 2024 2023 2022 Reconciliation of "All other" category: Stock-based compensation expense $ (120,834) $ (105,580) $ (83,507) Amortization of intangible assets (121,809) (132,126) (150,128) Restructuring-related charges (1) (92,764) (114,094) (2,121) Acquisition and integration-related costs (11,172) (23,311) (27,964) Goodwill impairment (2) (221,414) (12,411) (48,000) Charges associated with a long-term capacity reservation agreement (3) (38,419) (181,000) — Other (23,645) (2,758) (13,854) Loss from operations for "All other" $ (630,057) $ (571,280) $ (325,574) (1) Refer to Note 13 for additional information. (2) Refer to Note 7 for additional information. (3) Refer to Note 12 for additional information. The consolidated financial statements include revenue to customers by geographic region (based on the location of the customers' headquarters) that are summarized as follows (in thousands): Fiscal Year 2024 2023 2022 Revenue: United States $ 2,175,937 $ 1,817,960 $ 1,928,403 China 726,810 741,405 1,499,212 Other Asia 517,683 498,966 620,620 Taiwan 260,839 308,642 345,869 Europe 88,237 202,426 251,610 Total revenue $ 3,769,506 $ 3,569,399 $ 4,645,714 The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands): March 30, 2024 April 1, 2023 Long-lived tangible assets: United States $ 795,466 $ 929,446 China (1) 18,563 169,215 Other countries 56,953 51,145 (1) Fiscal 2024 excludes $133.4 million of property and equipment, net which has been reclassified to "Assets of disposal group held for sale." Refer to Note 4 for additional information.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Pay vs Performance Disclosure
Numerator for basic and diluted net (loss) income per share - net (loss) income available to common stockholders	$ (70,322)	$ 103,152	$ 1,033,353

Insider Trading Arrangements

Insider Trading Arrangements - shares		3 Months Ended
	Feb. 05, 2024	Mar. 30, 2024
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		OTHER INFORMATION. Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements The following table describes actions by our directors and Section 16 officers with respect to plans intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) during the fourth quarter of fiscal 2024. None of our directors or Section 16 officers took actions with respect to a "non-Rule 10b5-1 trading arrangement," as such term is defined in Item 408(c) of Regulation S-K, during the fourth quarter of fiscal 2024. Name and Title Action Date Expiration of Plan Number of Shares to be Sold (1) Robert A. Bruggeworth President and Chief Executive Officer and Director Adoption 2/5/2024 12/31/2024 106,714 Steven E. Creviston Senior Vice President and President of Connectivity & Sensors Adoption 2/5/2024 4/2/2025 30,000
Robert Bruggeworth [Member]
Trading Arrangements, by Individual
Name		Robert A. Bruggeworth
Title		President and Chief Executive Officer and Director
Rule 10b5-1 Arrangement Adopted		true
Adoption Date	2/5/2024
Termination Date		12/31/2024
Aggregate Available		106,714
Steven Creviston [Member]
Trading Arrangements, by Individual
Name		Steven E. Creviston Senior Vice President and President of Connectivity & Sensors
Rule 10b5-1 Arrangement Adopted		true
Adoption Date	2/5/2024
Termination Date		4/2/2025
Aggregate Available		30,000

The Company and Its Significa_2

The Company and Its Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the fiscal 2024 presentation.
Accounting Periods	Accounting Periods The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on March 30, 2024, April 1, 2023 and April 2, 2022. Fiscal years 2024, 2023, and 2022 were 52-week years.
Use of Estimates	Use of Estimates
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of demand deposit accounts, money market funds and other short-term, highly liquid investments with original maturities of three months or less when purchased.
Investments	Investments Marketable equity securities consist of common stock in publicly traded companies and are carried at fair value with both the realized and unrealized gains and losses reported in "Other income, net" in the Consolidated Statements of Operations. Fair values of publicly traded equity securities are determined using quoted prices in active markets. The marketable equity securities are classified as short-term based on their highly liquid nature and are recorded in "Other current assets" in the Consolidated Balance Sheets. The Company invests in limited partnerships which are accounted for using the equity method. These equity method investments are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company records its share of the financial results of the limited partnerships in "Other income, net" in the Company's Consolidated Statements of Operations. The Company also invests in privately held companies for which the fair value of the investment is not readily determinable. These equity investments without a readily determinable fair value are measured at cost less impairment, adjusted for any changes in observable prices and are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company assesses these investments for impairment on a quarterly basis and considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include the investee's financial condition and business outlook, market for technology and other relevant events and factors affecting the investee. Investments are impaired when their fair value is less than their carrying value.
Fair Value Measurement	Fair Value Measurement The Company measures and reports certain financial assets and liabilities on a recurring basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is described as follows: • Level 1 - includes instruments for which inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. • Level 2 - includes instruments for which the inputs are other than quoted prices that are observable for the asset or liability, either directly or indirectly. • Level 3 - includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. These inputs are supported by little or no market activity and reflect the use of significant management judgment. The Company also holds assets whose fair value is measured and recorded on a nonrecurring basis. These assets include equity method investments, equity investments without a readily determinable fair value and certain non-financial assets, such as intangible assets and property and equipment. Goodwill and intangible assets are adjusted to fair value after initial recognition only if an impairment charge is recognized, which is generally determined using a discounted cash flow model based on significant unobservable inputs (Level 3). During fiscal 2024, in connection with the acquisition of Anokiwave, Inc. ("Anokiwave"), the Company recorded intangible assets, which were recognized at fair value (refer to Note 6 for additional information). The fair value of these intangible assets was determined utilizing significant unobservable input assumptions (Level 3). During fiscal 2024, in connection with the Company’s agreement to divest its assembly and test operations in Beijing and Dezhou, China (the “Disposal Group”), the Company measured the Disposal Group at the lower of its carrying value or fair value less costs to sell (refer to Note 4 for additional information). The fair value of these assets was determined utilizing significant unobservable inputs (Level 3). The carrying values of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). Cost includes labor, materials and manufacturing overhead related to the purchase and production of inventories. In accordance with Accounting Standards Codification ("ASC") 330, "Inventory" , abnormal manufacturing costs are charged to "Cost of goods sold" in the Consolidated Statements of Operations in the period incurred rather than as a portion of inventory cost. The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against demand forecasts on a material or product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of demand forecasts and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold is recorded at the full inventory cost, net of the reserve.
Product Warranty	Product Warranty The Company generally sells products with a limited warranty against defects in materials and workmanship and non-conformance to applicable specifications. The majority of the Company’s product warranty claims are settled through the return of the defective product and the shipment of replacement product. Accruals are estimated based upon both historical experience as well as specifically identified claims. If there is a significant increase in the rate of customer claims compared with the Company's historical experience or if the Company's estimates of probable losses relating to specifically identified warranty exposures require revision, the Company may record a charge against future cost of sales. Product warranty accruals and related expenses were immaterial for the periods presented.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets. The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held and used by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as "held for sale" are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment of those assets, if any, is based on the excess of the carrying amount over the fair value less costs to sell.
Lessee, Leases [Policy Text Block]	Leases The Company determines that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists, the Company assesses whether it has the right to direct the use of the identified asset and obtain substantially all of the economic benefit from the use of the identified asset. Right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate in determining the present value of lease payments considering the term of the lease, which is derived from information available at the lease commencement date. The lease term includes options to extend or terminate the lease when it is reasonably certain such options will be exercised. To the extent that the Company's agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. The Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude from the balance sheet leases with an initial term of 12 months or less. The Company assesses right-of-use assets for impairment in accordance with its long-lived asset impairment policy.
Business Combinations Policy [Policy Text Block]	Business Acquisitions The Company allocates the fair value of the purchase price to the assets acquired and liabilities assumed based on their estimated fair value. The excess of the purchase price over the fair values of the identifiable assets and liabilities is recorded to goodwill. Goodwill is assigned to the Company's reporting unit that is expected to benefit from the synergies of the business combination. A number of assumptions, estimates and judgments are used in determining the fair value of acquired assets and liabilities, particularly with respect to the intangible assets acquired. The valuation of intangible assets requires the Company to use valuation techniques such as the income approach. The income approach includes management’s estimation of future cash flows (including expected revenue growth rates and profitability), the underlying product or technology life cycles and the discount rates applied to future cash flows. Judgment is also required in estimating the fair values of deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date, as well as inventory, property and equipment, pre-existing liabilities or legal claims, deferred revenue and contingent consideration, each as may be applicable. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. After the measurement period, any purchase price adjustments are recognized in the Consolidated Statements of Operations.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Impairment Testing In accordance with ASC 350, " Intangibles - Goodwill and Other " ("ASC 350"), goodwill is not amortized, but rather is reviewed for impairment at the reporting unit level on the first day of the Company's fourth quarter of each fiscal year, or when there is evidence that events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. Under ASC 350, the Company has the option to first assess qualitatively whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. In performing qualitative assessments, the Company considers the following factors which could trigger a goodwill impairment review: (i) significant underperformance relative to historical or projected future operating results; (ii) significant changes in the manner or use of the acquired assets or the strategy for the Company's overall business; (iii) significant negative industry or economic trends; (iv) a significant decline in the Company's stock price for a sustained period; and (v) a significant change in the Company's market capitalization relative to its net book value. If qualitative assessments conclude that it is more likely than not that the fair value of any reporting unit is less than its carrying value, quantitative assessments are performed on the applicable reporting units. The quantitative assessments consider both the income and market approaches to estimate the fair value of a reporting unit. The income approach is based on the discounted cash flow method that uses estimates of the reporting unit's revenue growth rates and operating margins as part of the Company's long-term planning process, taking into consideration historical data and industry and market conditions. The discount rate used to determine the present value of future cash flows is based on the weighted-average cost of capital adjusted for the relevant risk associated with business-specific characteristics and the uncertainty related to the ability to execute on the projected cash flows. The market approach estimates fair value based on market multiples of revenue and earnings derived from comparable publicly traded companies with similar operating and investment characteristics. Refer to Note 7 for additional information regarding goodwill and intangible asset impairment testing.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Identified Intangible Assets The Company amortizes definite-lived intangible assets (including developed technology, customer relationships, technology licenses and trade names) on a straight-line basis over their estimated useful lives. In-process research and development ("IPRD") assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of the acquisition and are initially not subject to amortization. Upon completion of development, IPRD assets are transferred to developed technology and are amortized over their useful lives. The asset balances relating to abandoned projects are impaired and expensed to R&D. The Company evaluates definite-lived intangible assets for impairment in accordance with ASC 360-10-35, " Impairment or Disposal of Long-Lived Assets " to determine whether facts and circumstances (including external factors such as industry and economic trends and internal factors such as changes in the Company’s business strategy and forecasts) indicate that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amounts over the fair value of those assets and are recognized in the period in which the impairment determination was made.
Revenue Recognition	Revenue Recognition The Company generates revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, or at completion of a consignment process. Revenue is recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. A majority of the Company's revenue is recognized at a point in time, either on shipment or delivery of the product, depending on individual customer terms and conditions. Revenue from sales to the Company’s distributors is recognized upon shipment of the product to the distributors (sell-in). Revenue is recognized from the Company’s consignment programs at a point in time when the products are pulled from consignment inventory by the customer. Revenue recognized for products and services over time is approximately 4% of overall revenue. The Company applies a five-step approach as defined in ASC 606, " Revenue from Contracts with Customers, " in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations in the contract; and (5) recognizing revenue when the corresponding performance obligation is satisfied. Sales agreements are in place with certain customers and contain terms and conditions with respect to payment, delivery, warranty and supply, but typically do not require minimum purchase commitments. In the absence of a sales agreement, the Company’s standard terms and conditions apply. The Company considers a customer's purchase order, which is governed by a sales agreement or the Company’s standard terms and conditions, to be the contract with the customer. The Company’s pricing terms are negotiated independently on a stand-alone basis. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. Variable consideration in the form of rebate programs is offered to certain customers, including distributors, and represents less than 10% of net revenue in fiscal 2024. The Company determines variable consideration by estimating the most likely amount of consideration it expects to receive from the customer. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company may authorize sales returns under certain circumstances, which include courtesy returns and like-kind exchanges. The Company reduces revenue and records reserves for product returns and allowances, rebate programs and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement. The Company’s accounts receivable balance is from contracts with customers and represents the Company’s unconditional right to receive consideration from its customers. Payments are due upon completion of the performance obligation and subsequent invoicing. Substantially all payments are collected within the Company’s standard terms, which do not include any financing components. There have been no material impairment losses on accounts receivable for fiscal years 2024, 2023 or 2022. Contract assets and contract liabilities recorded on the Consolidated Balance Sheets were immaterial as of March 30, 2024 and April 1, 2023. The Company invoices customers upon shipment and recognizes revenue in accordance with delivery terms. As of March 30, 2024, the Company had $76.9 million in remaining unsatisfied performance obligations with an original duration greater than one year, of which the majority is expected to be recognized as income over the next 12 months. The Company includes shipping charges billed to customers in "Revenue" and includes the related shipping costs in "Cost of goods sold" in the Consolidated Statements of Operations. Taxes assessed by government authorities on revenue-producing transactions, including tariffs, value-added taxes and excise taxes, are excluded from revenue in the Consolidated Statements of Operations. The Company incurs commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded in the "Selling, general and administrative" expense line item in the Consolidated Statements of Operations) are expensed when incurred because such commissions are not owed until the performance obligation is satisfied, which coincides with the end of the contract term, and therefore, no remaining period exists over which to amortize the commissions.
Research and Development	Research and Development The Company charges all R&D costs to expense as incurred.
Income Taxes	Income Taxes The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized. A more-likely-than-not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense. In accordance with ASC 740, " Income Taxes, " the Company recognizes a deferred tax liability for income taxes on unremitted foreign earnings of foreign subsidiaries which the Company intends to repatriate. If the Company asserts that such earnings will be permanently reinvested, a deferred tax liability is not recognized related to such earnings. It is the Company’s intent to repatriate all previously taxed earnings of foreign subsidiaries from outside the U.S.
Stock-Based Compensation	Stock-Based Compensation In accordance with ASC 718, " Compensation – Stock Compensation " ("ASC 718"), stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. As of March 30, 2024, total remaining unearned compensation cost related to unvested restricted stock units was $159.4 million, which will be amortized over the weighted-average remaining service period of approximately 1.4 years.
Foreign Currency Translation	Foreign Currency Translation The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with ASC 830, " Foreign Currency Matters. " The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenue and expenses are translated using the weighted-average exchange rates throughout the year. Translation adjustments are shown separately as a component of "Accumulated other comprehensive loss" within "Stockholders’ equity" in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in "Other income, net" in the Consolidated Statements of Operations.
Recent Accounting Pronouncements	Recent Accounting Pronouncements and Other Developments In August 2022, the Creating Helpful Incentives to Produce Semiconductors and Science Act (the "CHIPS Act") was signed into law. The CHIPS Act provides for a 25% refundable tax credit on certain investments in domestic semiconductor manufacturing. The credit is provided for qualifying property, which is placed in service after December 31, 2022. The CHIPS Act also provides for certain other financial incentives to further investments in domestic semiconductor manufacturing. The Company is evaluating the provisions of the law and its potential impact to the Company.
Supplemental financial information	Supplemental Financial Information The "Accrued liabilities" balance as of March 30, 2024 includes accrued compensation and benefits of $116.0 million and accrued rebates of $106.9 million. The "Accrued liabilities" balance as of April 1, 2023 includes accrued compensation and benefits of $92.9 million and accrued rebates of $42.8 million. The "Other current liabilities" balance as of March 30, 2024 includes income taxes payable of $59.9 million. The "Other current liabilities" balances as of April 1, 2023 includes income taxes payable of $63.6 million and contingent consideration related to the acquisition of United Silicon Carbide, Inc. ("United SiC") of $31.3 million, which was paid in fiscal 2024. "Other income, net" includes $38.3 million, $21.1 million and $2.7 million of interest income in fiscal years 2024, 2023 and 2022, respectively.

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Mar. 30, 2024
Inventory Disclosure [Abstract]
Components of inventories	The components of inventories, net of reserves, are as follows (in thousands): March 30, 2024 April 1, 2023 Raw materials $ 201,748 $ 264,367 Work in process 347,175 345,545 Finished goods 161,632 186,684 Total inventories $ 710,555 $ 796,596

Business Held For Sale (Tables)

Business Held For Sale (Tables)	12 Months Ended
	Mar. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	The carrying value of the major classes of assets and liabilities classified as held for sale as of March 30, 2024 are as follows (in thousands): Property and equipment, net $ 133,425 Other assets 39,115 Goodwill 22,000 Loss on classification as held for sale (35,262) Total assets of disposal group held for sale $ 159,278 Accounts payable and accrued liabilities $ 67,495 Other liabilities 20,877 Total liabilities of disposal group held for sale $ 88,372

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Mar. 30, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	The components of property and equipment are as follows (in thousands): March 30, 2024 (1) April 1, 2023 Land $ 23,039 $ 25,842 Building and leasehold improvements 354,037 463,888 Machinery and equipment 2,091,268 2,430,307 Construction in progress 86,230 130,086 Total property and equipment, gross 2,554,574 3,050,123 Less accumulated depreciation (1,683,592) (1,900,317) Total property and equipment, net $ 870,982 $ 1,149,806 (1) Excludes $133.4 million of property and equipment, net which has been reclassified to "Assets of disposal group held for sale." Refer to Note 4 for additional information.

Business Acquisitions Business

Business Acquisitions Business Acquisitions (Tables)	Feb. 05, 2024
Business Acquisitions [Abstract]
Aokiwave Purchase Price Allocation	The purchase price was preliminarily allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands): Intangible assets $ 47,700 Goodwill 16,140 Net tangible assets (1) 23,815 Deferred tax asset, net 6,030 Total purchase price $ 93,685 (1) Includes cash acquired of $10.7 million.

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Mar. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill [Table Text Block]	The changes in the carrying amount of goodwill for fiscal 2024 are as follows (in thousands): HPA CSG ACG Total Balance as of April 1, 2023 (1) $ 501,602 $ 525,351 $ 1,733,860 $ 2,760,813 Goodwill impairment — (221,414) — (221,414) Goodwill resulting from Anokiwave acquisition (2) 16,140 — — 16,140 Effect of changes in foreign currency exchange rates — 1,062 — 1,062 Goodwill reclassified to "Assets of disposal group held for sale" (3) (200) (4,700) (17,100) (22,000) Balance as of March 30, 2024 (1) $ 517,542 $ 300,299 $ 1,716,760 $ 2,534,601 (1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs totaling $903.4 million and $682.0 million as of March 30, 2024 and April 1, 2023, respectively, which were recognized in fiscal years 2009, 2013, 2014, 2022, 2023 and 2024. (2) Refer to Note 6 for additional information. (3) Refer to Note 4 for additional information.
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table Text Block]	The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands): March 30, 2024 April 1, 2023 Gross Accumulated Gross Accumulated Developed technology $ 903,089 $ 484,347 $ 872,106 $ 382,448 Customer relationships 100,040 67,999 104,616 67,485 Technology licenses 54,869 6,525 1,664 513 Trade names 1,610 939 910 789 IPRD 9,585 N/A 9,642 N/A Total (1) $ 1,069,193 $ 559,810 $ 988,938 $ 451,235 (1) Amounts include the impact of foreign currency translation.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	The following table provides the Company's estimated amortization expense for intangible assets for the periods indicated (in thousands): Fiscal Year Estimated 2025 $ 134,000 2026 123,000 2027 99,000 2028 58,000 2029 36,000

Investments and Fair Value Me_2

Investments and Fair Value Measurements (Tables)	12 Months Ended
	Mar. 30, 2024
Schedule of available-for-sale debt securities
Fair value of the financial assets measured at fair value on a recurring basis	The following table sets forth, by level within the fair value hierarchy, financial assets and liabilities measured on a recurring basis (in thousands): Total Quoted Prices In Significant Other Significant March 30, 2024 Marketable equity securities $ 84 $ 84 $ — $ — Invested funds in deferred compensation plan (1) 52,327 52,327 — — April 1, 2023 Marketable equity securities $ 1,094 $ 1,094 $ — $ — Invested funds in deferred compensation plan (1) 40,653 40,653 — — Contingent earn-out liability (2) (31,250) — — (31,250) (1) Invested funds under the Company's non-qualified deferred compensation plan are held in a rabbi trust and consist of mutual funds. The fair value of the mutual funds is calculated using the net asset value per share as determined by quoted active market prices of the underlying investments. Refer to Note 11 for further information on the Company's non-qualified deferred compensation plan. (2) The fair value of the contingent consideration liability which related to the acquisition of United SiC (refer to Note 6) was equal to the maximum amount payable at April 1, 2023 and was subsequently paid in the first quarter of fiscal 2024.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Mar. 30, 2024
Leases [Abstract]
Schedule of supplemental balance sheet information related to operating leases [Table Text Block]	Operating leases are classified in the Consolidated Balance Sheets as follows (in thousands): March 30, 2024 April 1, 2023 Other non-current assets (1) $ 61,293 $ 83,490 Other current liabilities (2) 15,601 19,357 Other long-term liabilities (2) 50,578 69,156 (1) The March 30, 2024 balance excludes $17.3 million of right-of-use assets which have been reclassified to "Assets of disposal group held for sale." Refer to Note 4 for additional information. (2) The March 30, 2024 balances exclude $2.7 million and $12.7 million of current lease liabilities and long-term lease liabilities, respectively, which have been reclassified to "Liabilities of disposal group held for sale." Refer to Note 4 for additional information.
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	The aggregate future lease payments for operating leases as of March 30, 2024 are as follows (in thousands): Fiscal Year Lease Payments (1) 2025 $ 17,185 2026 15,566 2027 11,945 2028 10,578 2029 5,840 Thereafter 13,335 Total future lease payments 74,449 Less imputed interest (8,270) Present value of lease liabilities $ 66,179 (1) Excludes future lease payments with a present value of $15.4 million which have been reclassified to "Liabilities of disposal group held for sale" on the Consolidated Balance Sheet. Refer to Note 4 for additional information.
Lease, Cost	Details of operating leases are as follows (in thousands): Fiscal Year 2024 2023 2022 Operating lease expense $ 21,531 $ 20,162 $ 19,178 Short-term lease expense 7,359 7,798 7,726 Variable lease expense 5,323 5,386 4,886 Cash paid for amounts included in the measurement of operating lease liabilities 22,471 21,480 20,536 Right-of-use assets obtained in exchange for new operating lease liabilities 11,750 28,940 29,210 The weighted-average remaining lease term and weighted-average discount rate for operating leases are as follows: March 30, 2024 April 1, 2023 Weighted-average remaining lease term (years) 6.3 6.5 Weighted-average discount rate 4.02 % 3.98 %

Debt (Tables)

Debt (Tables)	12 Months Ended
	Mar. 30, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	The following table summarizes the outstanding debt (in thousands): March 30, 2024 April 1, 2023 1.750% senior notes due 2024 $ 439,738 $ 500,000 4.375% senior notes due 2029 850,000 850,000 3.375% senior notes due 2031 700,000 700,000 Finance leases and other — 1,666 Unamortized premium, discount and issuance costs, net (1,726) (3,283) Total debt 1,988,012 2,048,383 Less current portion of debt (438,740) (310) Total long-term debt $ 1,549,272 $ 2,048,073

Restructuring Tables (Tables)

Restructuring Tables (Tables)	12 Months Ended
	Mar. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs [Table Text Block]	The following table summarizes fiscal 2024 charges resulting from the 2024 Restructuring Initiatives (in thousands): Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ — $ 7,213 $ 7,213 Asset impairment costs (1) 1,213 35,733 36,946 One-time employee termination benefits — 8,887 8,887 Total $ 1,213 $ 51,833 $ 53,046 (1) Refer to Note 4 for additional information. The following tables summarize, by fiscal year, the charges resulting from the 2023 Restructuring Initiatives (in thousands): Fiscal 2024 Cost of Goods Sold Other Operating Expense Total Contract termination and other costs $ 19,028 $ 4,244 $ 23,272 Asset impairment costs 2,159 9,307 11,466 One-time employee termination benefits — 2,681 2,681 Total $ 21,187 $ 16,232 $ 37,419 Fiscal 2023 Cost of Goods Sold Goodwill Impairment Other Operating Expense Total Contract termination and other costs $ 3,600 $ — $ 19,183 $ 22,783 Asset impairment costs (1) 43,004 12,411 45,422 100,837 One-time employee termination benefits — — 2,885 2,885 Total $ 46,604 $ 12,411 $ 67,490 $ 126,505 (1) Refer to Note 7 for additional information.
Restructuring Liabilities Rollforward	The following table summarizes the activity related to the Company's restructuring liabilities for fiscal years 2023 and 2024 (in thousands): One-Time Employee Termination Benefits Contract Termination and Other Costs Total Accrued restructuring balance, April 2, 2022 $ — $ — $ — Costs incurred and charged to expense 2,885 22,783 25,668 Cash payments (2,885) (17,535) (20,420) Accrued restructuring balance, April 1, 2023 $ — $ 5,248 $ 5,248 Costs incurred and charged to expense 11,568 32,785 44,353 Cash payments (3,789) (22,344) (26,133) Accrued restructuring balance, March 30, 2024 $ 7,779 $ 15,689 $ 23,468

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Mar. 30, 2024
Income Tax Disclosure [Abstract]
Income before income taxes	Income (loss) before income taxes consists of the following components (in thousands): Fiscal Year 2024 2023 2022 United States $ (281,790) $ (466,070) $ 69,938 Foreign 355,350 590,699 1,111,146 Total $ 73,560 $ 124,629 $ 1,181,084
Components of the income tax (provision) benefit	The components of the income tax provision are as follows (in thousands): Fiscal Year 2024 2023 2022 Current tax expense: Federal $ (36,155) $ (21,704) $ (16,886) State (232) (488) (274) Foreign (88,090) (65,430) (98,696) (124,477) (87,622) (115,856) Deferred tax (expense) benefit: Federal (6,532) 60,351 (18,398) State 1,090 2,371 (2,762) Foreign (13,963) 3,423 (10,715) (19,405) 66,145 (31,875) Total $ (143,882) $ (21,477) $ (147,731)
Reconciliation of the (provision for) or benefit from income taxes to income tax(expense) or benefit computed by applying the statutory federal income tax rate to pre-tax income.	A reconciliation of the provision for income taxes to income tax expense computed by applying the statutory federal income tax rate to pre-tax income for fiscal years 2024, 2023 and 2022 is as follows (dollars in thousands): Fiscal Year 2024 2023 2022 Amount Percentage Amount Percentage Amount Percentage Income tax expense at statutory federal rate $ (15,448) 21.0 % $ (26,172) 21.0 % $ (248,028) 21.0 % (Increase) decrease resulting from: State (expense) benefit, net of federal impact (1,028) 1.4 2,259 (1.8) (1,888) 0.2 Tax credits 67,726 (92.1) 97,809 (78.5) 118,877 (10.1) Effect of changes in income tax rate applied to net deferred tax assets (1) (150) 0.2 (950) 0.8 (25,679) 2.2 Foreign tax rate difference 46,102 (62.7) 73,491 (59.0) 148,932 (12.6) Foreign permanent differences and related items (5,540) 7.5 (10,852) 8.7 786 (0.1) Change in valuation allowance (7,537) 10.2 385 (0.3) 231 (0.1) Expiration of state and foreign attributes (1,947) 2.6 (1,962) 1.6 (3,048) 0.3 Stock-based compensation (10,696) 14.5 (9,036) 7.2 11,148 (0.9) Tax reserve adjustments (8,451) 11.5 (9,437) 7.6 (3,262) 0.3 U.S. tax on foreign earnings, including GILTI & FDII (2) (3) (129,692) 176.4 (128,708) 103.3 (130,874) 11.1 Tax on unremitted foreign earnings (3,283) 4.5 (402) 0.3 (1,033) 0.1 2024 Restructuring Initiative related adjustments (42,715) 58.1 — — — — Impairments and acquisition related adjustments (31,717) 43.2 (5,695) 4.5 (12,198) 1.0 Other income tax benefit (expense) 494 (0.7) (2,207) 1.8 (1,695) 0.1 $ (143,882) 195.6 % $ (21,477) 17.2 % $ (147,731) 12.5 % (1) In fiscal 2022, the Company negotiated an extension to its tax holiday in Singapore, resulting in the revaluation of its deferred tax assets. As a result, the Company recognized an income tax expense of $26.4 million due to the reduced tax rate. (2) The Global Intangible Low-Taxed Income ("GILTI") and Foreign-Derived Intangible Income ("FDII") provisions became effective for the Company in fiscal 2019, at which time the Company elected to treat taxes due on future GILTI inclusions in U.S. taxable income as a period cost. (3) Beginning in fiscal 2023 and as required by the Tax Cuts and Jobs Act, the Company was required to capitalize and amortize research and development expenses which were previously expensed for U.S. tax purposes.
Significant components of net deferred income taxes	Significant components of the Company’s net deferred income taxes are as follows (in thousands): March 30, 2024 April 1, 2023 Deferred income tax assets: Capitalized research and development expenses $ 60,875 $ 13,794 Research and other tax credits 54,681 57,048 Employee benefits 28,225 30,309 Net operating loss carryforwards 25,563 22,189 Inventories 16,290 24,374 Lease liabilities 14,395 18,768 Deferred revenue 153 14,475 Prepaid expenses 9 17,360 Other 12,736 15,898 Total deferred income tax assets 212,927 214,215 Valuation allowance (43,636) (35,896) Total deferred income tax assets, net of valuation allowance $ 169,291 $ 178,319 Deferred income tax liabilities: Intangible assets $ (71,912) $ (69,050) Property and equipment (48,139) (39,806) Accrued tax on unremitted foreign earnings (40,912) (25,948) Right-of-use assets (13,301) (17,457) Other (3,834) (2,645) Total deferred income tax liabilities (178,098) (154,906) Net deferred income tax (liability) asset $ (8,807) $ 23,413 Amounts included in the Consolidated Balance Sheets: Other non-current assets $ 25,400 $ 38,060 Other long-term liabilities (34,207) (14,647) Net deferred income tax (liability) asset $ (8,807) $ 23,413
Reconciliation of gross unrecognized tax benefits	A summary of the changes in the amount of gross unrecognized tax benefits is as follows (in thousands): Fiscal Year 2024 2023 2022 Beginning balance $ 152,331 $ 144,055 $ 134,068 Additions based on positions related to current year 5,298 9,718 11,826 Additions for tax positions in prior years 4,122 2,467 3,049 Reductions for tax positions in prior years (2,416) (363) (1,669) Expiration of statute of limitations (436) (3,546) (3,219) Ending balance $ 158,899 $ 152,331 $ 144,055
Summary of Valuation Allowance	The components of the change in valuation allowances and ending balances are as follows (in thousands): Fiscal Year 2024 2023 2022 Beginning valuation allowance $ 35,896 $ 36,281 $ 36,512 Domestic net operating losses and credits (3,164) 583 1,339 Foreign net operating losses and other deferred tax assets 10,904 (968) (1,570) Ending valuation allowance $ 43,636 $ 35,896 $ 36,281 Components of ending valuation allowance: Domestic deferred tax assets $ 32,406 $ 35,570 $ 34,987 Foreign deferred tax assets 11,230 326 1,294 Valuation allowance $ 43,636 $ 35,896 $ 36,281

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	12 Months Ended
	Mar. 30, 2024
Earnings Per Share [Abstract]
Reconciliation of the numerators and denominators in the computation of basic and diluted net income (loss) per share	The following table sets forth the computation of basic and diluted net (loss) income per share (in thousands, except per share data): Fiscal Year 2024 2023 2022 Numerator: Numerator for basic and diluted net (loss) income per share — net (loss) income available to common stockholders $ (70,322) $ 103,152 $ 1,033,353 Denominator: Denominator for basic net (loss) income per share — weighted-average shares 97,557 102,206 110,196 Effect of dilutive securities: Stock-based awards — 813 1,350 Denominator for diluted net (loss) income per share — adjusted weighted-average shares and assumed conversions 97,557 103,019 111,546 Basic net (loss) income per share $ (0.72) $ 1.01 $ 9.38 Diluted net (loss) income per share $ (0.72) $ 1.00 $ 9.26

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Mar. 30, 2024
Share-Based Payment Arrangement [Abstract]
Summary of activity of the Company's director and employee stock option plans	A summary of activity with respect to stock options under the Company’s director and employee stock plans follows: Options Weighted- Weighted-Average Remaining Contractual Term (in years) Aggregate Outstanding as of April 1, 2023 69 $ 20.95 Granted — — Exercised (66) $ 20.13 Canceled (2) $ 15.47 Forfeited — — Outstanding as of March 30, 2024 1 $ 67.84 0.83 $ 65 Vested and expected to vest as of March 30, 2024 1 $ 67.84 0.83 $ 65 Options exercisable as of March 30, 2024 1 $ 67.84 0.83 $ 65
Restricted share plans	A summary of activity with respect to restricted stock units ( " RSUs " ) under the Company’s director and employee stock plans follows: RSUs Weighted-Average Unvested balance as of April 1, 2023 1,832 $ 118.38 Granted 1,340 102.14 Vested (830) 112.19 Forfeited (118) 115.85 Unvested balance as of March 30, 2024 2,224 $ 111.32

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Mar. 30, 2024
Equity [Abstract]
Common stock reserved for future issuance	As of March 30, 2024, the Company had reserved a total of approximately 7.5 million of its authorized 405.0 million shares of common stock for possible future issuance as follows (in thousands): Company stock incentive plans 3,088 Employee stock purchase plan 2,160 Unvested restricted stock units 2,224 Total shares reserved 7,472

Operating Segment and Geograp_2

Operating Segment and Geographical Information (Tables)	12 Months Ended
	Mar. 30, 2024
Segment Reporting [Abstract]
Sales to customers by geographic region	The consolidated financial statements include revenue to customers by geographic region (based on the location of the customers' headquarters) that are summarized as follows (in thousands): Fiscal Year 2024 2023 2022 Revenue: United States $ 2,175,937 $ 1,817,960 $ 1,928,403 China 726,810 741,405 1,499,212 Other Asia 517,683 498,966 620,620 Taiwan 260,839 308,642 345,869 Europe 88,237 202,426 251,610 Total revenue $ 3,769,506 $ 3,569,399 $ 4,645,714
Long-lived assets by geographic region	The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands): March 30, 2024 April 1, 2023 Long-lived tangible assets: United States $ 795,466 $ 929,446 China (1) 18,563 169,215 Other countries 56,953 51,145 (1) Fiscal 2024 excludes $133.4 million of property and equipment, net which has been reclassified to "Assets of disposal group held for sale." Refer to Note 4 for additional information.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]	The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands): Fiscal Year 2024 2023 2022 Revenue: HPA $ 572,953 $ 727,187 $ 707,395 CSG 434,537 474,364 703,881 ACG 2,762,016 2,367,848 3,234,438 Total revenue $ 3,769,506 $ 3,569,399 $ 4,645,714 Operating income (loss): HPA $ 82,501 $ 198,820 $ 210,441 CSG (88,649) (72,080) 107,814 ACG 727,906 627,708 1,233,388 All other (630,057) (571,280) (325,574) Operating income 91,701 183,168 1,226,069 Interest expense (69,245) (68,463) (63,326) Other income, net 51,104 9,924 18,341 Income before income taxes $ 73,560 $ 124,629 $ 1,181,084 Fiscal Year 2024 2023 2022 Reconciliation of "All other" category: Stock-based compensation expense $ (120,834) $ (105,580) $ (83,507) Amortization of intangible assets (121,809) (132,126) (150,128) Restructuring-related charges (1) (92,764) (114,094) (2,121) Acquisition and integration-related costs (11,172) (23,311) (27,964) Goodwill impairment (2) (221,414) (12,411) (48,000) Charges associated with a long-term capacity reservation agreement (3) (38,419) (181,000) — Other (23,645) (2,758) (13,854) Loss from operations for "All other" $ (630,057) $ (571,280) $ (325,574) (1) Refer to Note 13 for additional information. (2) Refer to Note 7 for additional information. (3) Refer to Note 12 for additional information.

The Company and Its Significa_3

The Company and Its Significant Accounting Policies (Details) - USD ($) $ in Thousands		3 Months Ended		12 Months Ended
	Aug. 09, 2022	Dec. 30, 2023	Sep. 30, 2023	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
The Company and Its Significant Accounting Policies [Line Items]
Revenue for product and services over time as a percent of total revenue				4%
Revenue, Remaining Performance Obligation, Amount				$ 76,900
Rebates As Percentage Of Sales [Less Than]				10%
Total remaining unearned compensation cost related to nonvested restricted stock units and options				$ 0
Goodwill impairment		$ 173,400	$ 48,000	221,414	$ 12,411	$ 48,000
Other Liabilities, Current				113,215	122,289
Increase (Decrease) in Income Taxes Payable				8,681	(33,240)	(3,139)
Taxes Payable, Current				59,900	63,600
Employee-related Liabilities, Current				116,000	92,900
Accrued Rebate				106,900	42,800
Investment tax credit, Percent	25%
Interest Income, Operating and Nonoperating				$ 38,300	$ 21,100	$ 2,700
Minimum
The Company and Its Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life				1 year
Maximum
The Company and Its Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life				39 years
Restricted Stock
The Company and Its Significant Accounting Policies [Line Items]
Total remaining unearned compensation cost related to nonvested restricted stock units and options				$ 159,400
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units and options				1 year 4 months 24 days

Concentrations of Credit Risk (

Concentrations of Credit Risk (Details)	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Revenue from significant customers
Three largest accounts receivable balances percentage [Line Items]	60%	54%
Sales Revenue, Net | Customer Concentration Risk | Apple
Revenue from significant customers
Percentage	12%	12%	11%
Percentage	12%	12%	11%
Sales Revenue, Net | Customer Concentration Risk | Apple
Revenue from significant customers
Percentage	46%	37%	33%
Percentage	46%	37%	33%

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Mar. 30, 2024	Apr. 01, 2023
Components of inventories
Raw materials	$ 201,748	$ 264,367
Work in process	347,175	345,545
Finished goods	161,632	186,684
Total inventories	$ 710,555	$ 796,596

Business Held For Sale (Details

Business Held For Sale (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 30, 2024	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022	Dec. 16, 2023
Discontinued Operations and Disposal Groups [Abstract]
Disposal Group, Including Discontinued Operation, Consideration					$ 240,000
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment	$ 133,425	$ 133,425
Disposal Group, Including Discontinued Operation, Other Assets	39,115	39,115
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent	22,000	22,000
Loss on classification as held for sale	35,300	(35,262)	$ 0	$ 0
Disposal Group, Including Discontinued Operation, Assets	159,278	159,278	0
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations	88,372	88,372	$ 0
Disposal Group, Including Discontinued Operation, Liabilities	67,495	67,495
Disposal Group, Including Discontinued Operation, Other Liabilities	20,877	20,877
Disposal Group, Including Discontinued Operation, Goodwill	$ 22,000	$ 22,000

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 30, 2024	Apr. 01, 2023
Property, Plant and Equipment [Abstract]
Land	$ 23,039	$ 25,842
Building and leasehold improvements	354,037	463,888
Machinery and equipment	2,091,268	2,430,307
Construction in progress	86,230	130,086
Property, Plant and Equipment, Gross	2,554,574	3,050,123
Less accumulated depreciation	(1,683,592)	(1,900,317)
Property and equipment, net	870,982	$ 1,149,806
Property, Plant and Equipment [Line Items]
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment	$ 133,425

Business Acquisitions (Details

Business Acquisitions (Details Textual) - USD ($) $ in Thousands				12 Months Ended
	Feb. 05, 2024	Oct. 19, 2021	Apr. 05, 2021	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Business Acquisition [Line Items]
Goodwill, Acquired During Period				$ 2,534,601	$ 2,760,813
BUSINESS ACQUISITIONS				BUSINESS ACQUISITIONS During fiscal 2024, the Company completed the acquisition of Anokiwave. During fiscal 2022, the Company completed the acquisitions of United SiC and NextInput, Inc. ("NextInput"). The goodwill resulting from these acquisitions is attributed to synergies and other benefits that are generated from these transactions. The operating results of these companies, which were not material either individually or in the aggregate, have been included in the Company's consolidated financial statements as of the acquisition dates. As a result, pro forma results of operations for these acquisitions have not been presented. Anokiwave, Inc. On February 5, 2024, the Company acquired all the outstanding equity interests of Anokiwave, a leading supplier of high-performance beamforming and mixed signal integrated circuits ("ICs") enabling intelligent active array antennas for defense and aerospace, satellite communication and 5G applications, for a total purchase price of $93.7 million. The acquisition added high-frequency beamforming and intermediate frequency to RF conversion ICs to the Company's broad RF offerings enabling complete RF system solutions. The purchase price was preliminarily allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands): Intangible assets $ 47,700 Goodwill 16,140 Net tangible assets (1) 23,815 Deferred tax asset, net 6,030 Total purchase price $ 93,685 (1) Includes cash acquired of $10.7 million. The significant intangible assets acquired included developed technology of $34.0 million and customer relationships of $13.0 million . The fair value of the developed technology acquired was determined based on an income approach using the "excess earnings method" which estimated the value of the intangible asset by discounting the future projected earnings of the asset to present value as of the valuation date. The acquired developed technology asset is being amortized on a straight-line basis over its estimated useful life of seven years. The fair value of the customer relationships acquired was determined based on an income approach using the "with and without method" in which the value of the intangible asset is determined by the difference in discounted cash flows of the profitability of the Company "with" the asset and the profitability of the Company "without" the asset. These customer relationships are being amortized on a straight-line basis over the estimated useful life of two years. The Company will continue to evaluate certain assets, liabilities and tax estimates over the measurement period (up to one year from the acquisition date). Goodwill recognized from the acquisition of Anokiwave has been assigned to the HPA segment and is not deductible for income tax purposes. During fiscal 2024, the Company recorded acquisition and integration-related costs associated with the acquisition of Anokiwave totaling $6.4 million in "Other operating expense" in the Consolidated Statement of Operations. During fiscal 2024, the Company also recorded $1.3 million of acquisition and integration-related costs in "Cost of goods sold" in the Consolidated Statement of Operations. United Silicon Carbide, Inc. On October 19, 2021, the Company acquired all the outstanding equity interests of United SiC, a leading manufacturer of silicon carbide ("SiC") power semiconductors, for a total purchase price of $236.7 million. The acquisition expanded the Company's offerings to include SiC power products for a range of applications such as electric vehicles, battery charging, IT infrastructure, renewables and circuit protection. The purchase price comprised cash consideration of $227.2 million and contingent consideration of up to $31.3 million which was paid to the sellers during the first quarter of fiscal 2024 (in accordance with the terms of the acquisition agreement) due to the achievement of certain revenue and gross margin targets over the period beginning on the acquisition date through December 31, 2022. During fiscal years 2024, 2023 and 2022, the Company recorded acquisition and integration-related costs associated with the acquisition of United SiC totaling $0.9 million, $14.6 million and $12.2 million, respectively, in "Other operating expense" in the Consolidated Statements of Operations. During fiscal 2022, the Company also recorded $3.6 million of acquisition and integration-related costs in "Cost of goods sold" in the Consolidated Statement of Operations. NextInput, Inc. On April 5, 2021, the Company acquired all the outstanding equity interests of NextInput, a leader in microelectromechanical system ("MEMS")-based sensing solutions, for a total cash purchase price of $173.3 million. The acquisition expanded the Company's offerings of MEMS-based products for mobile applications, providing sensing solutions for a broad range of applications in other markets. In connection with the Company's fiscal 2022 annual qualitative goodwill impairment assessment, it was determined that the market adoption of the acquired NextInput technology into mobile handsets was expected to be delayed compared to the previous assumptions. As a result, the Company completed a quantitative assessment of its reporting unit, which resulted in a goodwill impairment charge of $48.0 million. Other Acquisitions
In-process research and development
Business Acquisition [Line Items]
IPRD				$ 9,585	9,642
7Hugs
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross		$ 227,200
Business Combination, Consideration Transferred		236,700
Business Combination, Contingent Consideration, Liability					31,300
NextInput
Business Acquisition [Line Items]
Business Combination, Consideration Transferred			$ 173,300
Anokiwave
Business Acquisition [Line Items]
Business Combination, Net Tangible Assets Acquired	$ (23,815)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities	6,030
Goodwill, Acquired During Period	16,140
Business Combination, Consideration Transferred	93,685
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	47,700
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	10,700
Technology-Based Intangible Assets | Anokiwave
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 34,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	7 years
Customer-Related Intangible Assets | Anokiwave
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	$ 13,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	2 years
Maximum | 7Hugs
Business Acquisition [Line Items]
Business Combination, Contingent Consideration, Liability		$ 31,300
Other Operating Income (Expense) [Member] | 7Hugs
Business Acquisition [Line Items]
Integration related costs				900	14,600	$ 12,200
Other Operating Income (Expense) [Member] | Other Acquisition
Business Acquisition [Line Items]
Integration related costs				2,600	8,700	$ 12,200
Other Operating Income (Expense) [Member] | Anokiwave
Business Acquisition [Line Items]
Integration related costs				6,400
Cost of Sales [Member] | 7Hugs
Business Acquisition [Line Items]
Integration related costs					$ 3,600
Cost of Sales [Member] | Anokiwave
Business Acquisition [Line Items]
Integration related costs				$ 1,300

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Details 1) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022	Feb. 05, 2024
Goodwill and Intangible Assets [Line Items]
Goodwill impairment	$ 173,400	$ 48,000	$ 221,414	$ 12,411	$ 48,000
Gross carrying amounts and amortization of intangibles
Accumulated Amortization			559,810	451,235
Goodwill, Foreign Currency Translation Gain (Loss)			1,062
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent			22,000
Gross Carrying Amount			1,069,193	988,938
Goodwill, Acquired During Period			2,534,601	2,760,813
Technology licenses
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			54,869	1,664
Accumulated Amortization			6,525	513
Customer Relationships
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			100,040	104,616
Accumulated Amortization			67,999	67,485
Developed Technology
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			903,089	872,106
Accumulated Amortization			484,347	382,448
Trade Names
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			1,610	910
Accumulated Amortization			939	789
United Silicon Carbide
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments			16,140
Anokiwave
Gross carrying amounts and amortization of intangibles
Goodwill, Acquired During Period						$ 16,140
HPA
Goodwill and Intangible Assets [Line Items]
Goodwill impairment			0
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)			0
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent			200
Goodwill, Acquired During Period			517,542	501,602
HPA | Anokiwave
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments			16,140
CSG
Goodwill and Intangible Assets [Line Items]
Goodwill impairment			221,414
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)			1,062
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent			4,700
Goodwill, Acquired During Period			300,299	525,351
CSG | United Silicon Carbide
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments			0
ACG
Goodwill and Intangible Assets [Line Items]
Goodwill impairment			0
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)			0
Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent			17,100
Goodwill, Acquired During Period			1,716,760	$ 1,733,860
ACG | United Silicon Carbide
Goodwill and Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments			$ 0

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Details 2) $ in Thousands	Mar. 30, 2024 USD ($)
Estimated Amortization Expense
Finite-Lived Intangible Asset, Expected Amortization, Year One	$ 134,000
Finite-Lived Intangible Asset, Expected Amortization, Year Two	123,000
Finite-Lived Intangible Asset, Expected Amortization, Year Three	99,000
Finite-Lived Intangible Asset, Expected Amortization, Year Four	58,000
Finite-Lived Intangible Asset, Expected Amortization, Year Five	$ 36,000

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Details 3) - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization	$ 127,898	$ 132,425	$ 150,466
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD	$ 9,585	$ 9,642

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets (Details Textual) $ in Thousands	12 Months Ended
	Mar. 30, 2024 USD ($)	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 2,534,601	$ 2,760,813
Accumulated impairment losses and write-offs	903,400	682,000
Amortization of Intangible Assets	127,898	132,425	$ 150,466
Finite-Lived Intangible Assets, Accumulated Amortization	$ 559,810	451,235
Number of Reporting Units	7
Developed Technology
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ 484,347	382,448
Customer Relationships
Goodwill and Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Accumulated Amortization	$ 67,999	$ 67,485

Investments and Fair Value Me_3

Investments and Fair Value Measurements (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Proceeds from Limited Partnership Investments	$ 3,200	$ 2,500	$ 14,800
Equity Method Investments	16,000	20,400
Gain (Loss) on Investments	1,200	4,200	$ 12,000
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	52,327	40,653
Business Combination, Contingent Consideration, Liability		31,250
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	52,327	40,653
Business Combination, Contingent Consideration, Liability		0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	0	0
Business Combination, Contingent Consideration, Liability		0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	0	0
Business Combination, Contingent Consideration, Liability		31,250
Equity Securities | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	84	1,094
Equity Securities | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	84	1,094
Equity Securities | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	0	0
Equity Securities | Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	$ 0	$ 0

Leases (Details)

Leases (Details) $ in Thousands	12 Months Ended
	Mar. 30, 2024 USD ($)	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)
Lessee, Lease, Description [Line Items]
Operating lease expense	$ 21,531	$ 20,162	$ 19,178
Short-term lease expense	7,359	7,798	7,726
Variable lease expense	5,323	5,386	4,886
Operating Lease, Payments	22,471	21,480	20,536
Operating lease assets obtained in exchange for new lease liabilities	$ 11,750	$ 28,940	$ 29,210
Weighted-average remaining lease term (years) - operating leases	6 years 3 months 18 days	6 years 6 months
Weighted-average discount rate - operating leases	4.02%	3.98%
Less imputed interest	$ (8,270)
2025	17,185
2026	15,566
2027	11,945
2028	10,578
2029	5,840
Thereafter	13,335
Total lease payments	74,449
Present value of lease liabilities	66,179
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations	$ (88,372)	$ 0
Lessor, Operating Lease, Renewal Term	10 years
Disposal Group, Including Discontinued Operation, Operating Lease Right of Use	$ 17,300
Operating lease asset	61,293	83,490
Current operating lease liability	15,601	19,357
Non-current operating lease liability	$ 50,578	$ 69,156
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Current	Other Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Lessor, Operating Lease, Number of Renewal Term	2
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations
Lessee, Lease, Description [Line Items]
Disposal Group, Including Discontinued Operation, Liabilities, Current	$ 2,700
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent	12,700
Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations	$ (15,400)

Debt (Details)

Debt (Details)					3 Months Ended	12 Months Ended
	Apr. 23, 2024 USD ($)	Sep. 29, 2020 USD ($)	Jun. 11, 2020 USD ($)	Jul. 16, 2018	Mar. 30, 2024 USD ($)	Mar. 30, 2024 USD ($)	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)	Sep. 30, 2023	Apr. 06, 2022	Dec. 14, 2021 USD ($)	Dec. 20, 2019 USD ($)	Sep. 30, 2019 USD ($)
Debt Instrument [Line Items]
Total long-term debt					$ 1,549,272,000	$ 1,549,272,000	$ 2,048,073,000
Interest Expense, Borrowings						72,100,000	72,300,000	$ 67,000,000
Long-term Debt, Current Maturities					438,740,000	438,740,000	310,000
Net carrying amount of debt					1,549,272,000	1,549,272,000	2,048,073,000
Unamortized premium and issuance costs, net					1,726,000	1,726,000	3,283,000
Debt, Long-Term and Short-Term, Combined Amount					1,988,012,000	1,988,012,000	2,048,383,000
Senior Notes Due 2029 4.375% [Member]
Debt Instrument [Line Items]
Total long-term debt					850,000,000	850,000,000	850,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities						37,200,000
Debt Instrument, Face Amount			$ 300,000,000									$ 200,000,000	$ 350,000,000
Debt Instrument, Interest Rate, Stated Percentage													4.375%
Long-term Debt, Fair Value					797,600,000	797,600,000	785,900,000
Debt Instrument, Redemption Price, Percentage			104.375%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed				35%
Interest paid						37,200,000
Net carrying amount of debt					850,000,000	850,000,000	850,000,000
Debt Instrument, Redemption Price, Percentage, Excluding Make-Whole Premium			1
Credit Agreement [Member]
Debt Instrument [Line Items]
debt instrument, covenant, Consolidated Leverage Ratio									4
Finance leases [Member]
Debt Instrument [Line Items]
Total long-term debt					0	0	1,666,000
Net carrying amount of debt					0	0	1,666,000
3.375% Senior Notes due 2031
Debt Instrument [Line Items]
Total long-term debt					700,000,000	700,000,000	700,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities						11,800,000	23,600,000	23,600,000
Debt Instrument, Face Amount		$ 700,000,000
Debt Instrument, Interest Rate, Stated Percentage		3.375%
Long-term Debt, Fair Value					603,800,000	603,800,000	565,300,000
Debt Instrument, Redemption Price, Percentage		103.375%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed		40%
Interest paid						11,800,000	23,600,000	23,600,000
Net carrying amount of debt					700,000,000	700,000,000	700,000,000
Debt Instrument, Redemption Price, Percentage, Excluding Make-Whole Premium		1
Senior Notes Due 2024 1.750%
Debt Instrument [Line Items]
Total long-term debt					439,738,000	439,738,000	500,000,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities						8,600,000	8,800,000
Debt Instrument, Face Amount					439,700,000	439,700,000					$ 500,000,000
Debt Instrument, Interest Rate, Stated Percentage											1.75%
Long-term Debt, Fair Value					426,900,000	426,900,000	464,200,000
Interest paid						8,600,000	8,800,000
Net carrying amount of debt					439,738,000	439,738,000	500,000,000
Debt Instrument, Repurchased Face Amount					$ 60,300,000	60,300,000
Senior Notes
Debt Instrument [Line Items]
Interest Costs Capitalized						$ 2,900,000	$ 3,900,000	$ 3,700,000
2024 Credit Agreement
Debt Instrument [Line Items]
debt instrument, covenant, Consolidated Leverage Ratio					3.50	3.50
Gain (Loss) on Repurchase of Debt Instrument					$ 1,800,000
2024 Credit Agreement | Federal Funds Rate | Subsequent Event
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.50%
2024 Credit Agreement | Base Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										0.25%
2024 Credit Agreement | Base Rate | Subsequent Event
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1%
2024 Credit Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										1.25%
2024 Credit Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Subsequent Event
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.10%
2024 Credit Agreement | Maximum | Base Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										0.75%
2024 Credit Agreement | Maximum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										1.75%
2024 Credit Agreement | Maximum | Loan Purchase Commitments | Subsequent Event
Debt Instrument [Line Items]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.275%
2024 Credit Agreement | Minimum | Base Rate
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										0%
2024 Credit Agreement | Minimum | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Subsequent Event
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1%
2024 Credit Agreement | Minimum | Loan Purchase Commitments | Subsequent Event
Debt Instrument [Line Items]
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.125%
Revolving Credit Facility | Credit Agreement [Member]
Debt Instrument [Line Items]
Proceeds from Lines of Credit						$ 0
Business Combination, Consideration Transferred						$ 300,000,000
Revolving Credit Facility | 2024 Credit Agreement | Subsequent Event
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 325,000,000
Revolving Credit Facility | 2024 Credit Agreement | Swing line advances | Subsequent Event
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	10,000,000
Revolving Credit Facility | 2024 Credit Agreement | Standby Letters of Credit | Subsequent Event
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 25,000,000

Retirement Benefit Plans (Detai

Retirement Benefit Plans (Details) $ in Millions	12 Months Ended
	Mar. 30, 2024 USD ($)	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)
Retirement Benefit Plan (Textual)
Defined Contribution Plan, Company Contribution Amount	$ 20.3	$ 18.8	$ 17.6
Defined Benefit Pension Plan, Net Periodic Benefit Cost	0.5		$ 0.6
Assets held in rabbi trust	52.3	40.7
Assets held in rabbi trust, current	2.3	1.6
Assets held in rabbi trust, noncurrent	50	39.1
Foreign Plan [Member]
Retirement Benefit Plan (Textual)
Defined benefit plan insurance receivable	3.8
Defined Benefit Pension Plan, Benefit Obligation	$ 9.6	$ 9.4
Number of retirement benefit plans offered by the Company	2

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended		24 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Mar. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Purchase Obligation	$ 527,400		$ 527,400
Purchase Obligation, to be Paid, Year One	487,100		487,100
Purchase Obligation, to be Paid, Year Two	24,200		24,200
Purchase Obligation, to be Paid, Year Three	11,700		11,700
Purchase Obligation, to be Paid, Year Four	4,400		4,400
Unrecorded Unconditional Purchase Obligation [Line Items]
Other Liabilities, Noncurrent	218,904	$ 185,273	218,904
Other Liabilities, Current	113,215	122,289	113,215
Capitalized Contract Cost, Impairment Loss	38,400	181,000
Restructuring related charges	44,353	25,668
Purchase Obligation, to be Paid, Year Two	24,200		24,200
fiscal year 2023
Unrecorded Unconditional Purchase Obligation [Line Items]
Restructuring related charges	37,419	126,505	$ 163,900
Cost of sales | fiscal year 2023
Unrecorded Unconditional Purchase Obligation [Line Items]
Restructuring related charges	$ 21,187	$ 46,604

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended				24 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Mar. 29, 2025	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022	Mar. 30, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 44,353	$ 25,668
Goodwill impairment	$ 173,400	$ 48,000		221,414	12,411	$ 48,000
Restructuring Reserve				23,468	5,248	0	$ 23,468
Payments for Restructuring				(26,133)	(20,420)
fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				37,419	126,505		163,900
fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				53,046
fiscal year 2024 | Minimum
Restructuring Cost and Reserve [Line Items]
Restructuring related charges			$ 5,000
fiscal year 2024 | Maximum
Restructuring Cost and Reserve [Line Items]
Restructuring related charges			$ 10,000
Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				32,785	22,783
Restructuring Reserve				15,689	5,248	0	15,689
Payments for Restructuring				(22,344)	(17,535)
Contract Termination [Member] | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				23,272	22,783
Contract Termination [Member] | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				7,213
impairment charges | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				11,466	100,837
impairment charges | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				36,946
One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				11,568	2,885
Restructuring Reserve				7,779	0	$ 0	$ 7,779
Payments for Restructuring				(3,789)	(2,885)
One-time termination benefits | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				2,681	2,885
One-time termination benefits | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				8,887
Cost of sales | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 21,187	$ 46,604
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold	Cost of goods sold
Cost of sales | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 1,213
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold
Cost of sales | Contract Termination [Member] | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 19,028	$ 3,600
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold	Cost of goods sold
Cost of sales | Contract Termination [Member] | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 0
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold
Cost of sales | impairment charges | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 2,159	$ 43,004
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold	Cost of goods sold
Cost of sales | impairment charges | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 1,213
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold
Cost of sales | One-time termination benefits | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 0	$ 0
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold	Cost of goods sold
Cost of sales | One-time termination benefits | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 0
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold
Other operating expense | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 16,232	$ 67,490
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold	Cost of goods sold
Other operating expense | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 51,833
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold
Other operating expense | Contract Termination [Member] | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 4,244	$ 19,183
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold	Cost of goods sold
Other operating expense | Contract Termination [Member] | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 7,213
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold
Other operating expense | impairment charges | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 9,307	$ 45,422
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold	Cost of goods sold
Other operating expense | impairment charges | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 35,733
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold
Other operating expense | One-time termination benefits | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 2,681	$ 2,885
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold	Cost of goods sold
Other operating expense | One-time termination benefits | fiscal year 2024
Restructuring Cost and Reserve [Line Items]
Restructuring related charges				$ 8,887
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of goods sold
Impaired Goodwill | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges					$ 12,411
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]					Cost of goods sold
Impaired Goodwill | Contract Termination [Member] | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges					$ 0
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]					Cost of goods sold
Impaired Goodwill | impairment charges | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges					$ 12,411
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]					Cost of goods sold
Impaired Goodwill | One-time termination benefits | fiscal year 2023
Restructuring Cost and Reserve [Line Items]
Restructuring related charges					$ 0
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]					Cost of goods sold

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Income (loss) before income taxes
United States	$ (281,790)	$ (466,070)	$ 69,938
Foreign	355,350	590,699	1,111,146
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	73,560	124,629	1,181,084
Valuation Allowance [Line Items]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	5,300	1,900	1,000
Income (Loss) from Continuing Operations before Income Taxes, Domestic	(281,790)	(466,070)	69,938
Income (Loss) from Continuing Operations before Income Taxes, Foreign	355,350	590,699	1,111,146
Deferred Tax Liabilities, Gross	178,098	154,906
Deferred Tax Liabilities, Net	(8,807)
Deferred Tax Assets, in Process Research and Development	54,681	57,048
Deferred Tax Assets, Operating Loss Carryforwards	25,563	22,189
Unrecognized Tax Benefits, Expected to be Recognized Within the Next 12 Months	24,900
Inventories	14,395	18,768
Deferred tax assets, Prepaids	9	17,360
Deferred tax assets, Deferred Revenue	153	14,475
Capitalized research and development expenses	60,875	13,794
Other non-current assets	25,400	38,060
Other long-term liabilities	34,207	14,647
Valuation Allowance	43,636	35,896	36,281	$ 36,512
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	7,700		200
Geographic Distribution, Domestic
Valuation Allowance [Line Items]
Valuation Allowance	32,406	35,570	34,987
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	(3,164)	583	1,339
Geographic Distribution, Foreign
Valuation Allowance [Line Items]
Valuation Allowance	11,230	326	1,294
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 10,904	(968)	$ (1,570)
tax holiday
Valuation Allowance [Line Items]
Deferred Income Taxes and Tax Credits		$ 26,400

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Current (expense) benefit:
Federal	$ (36,155)	$ (21,704)	$ (16,886)
State	(232)	(488)	(274)
Foreign	(88,090)	(65,430)	(98,696)
Total current (expense) benefit	(124,477)	(87,622)	(115,856)
Deferred (expense) benefit:
Federal	(6,532)	60,351	(18,398)
State	1,090	2,371	(2,762)
Foreign	(13,963)	3,423	(10,715)
Total deferred (expense) benefit	(19,405)	66,145	(31,875)
Income tax expense (benefit)	$ 143,882	$ 21,477	$ 147,731

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
ReconciliationOfProvisionOfIncomeTaxes [Line Items]
Deferred Income Tax Expense (Benefit)	$ 19,405	$ (66,145)	$ 31,875
Income tax expense at statutory federal rate	$ (15,448)	$ (26,172)	$ (248,028)
Income tax expense at statutory federal rate, Percentage	21%	21%	21%
Decrease (increase) resulting from:
State benefit (provision), net of federal (provision) benefit	$ (1,028)	$ 2,259	$ (1,888)
State benefit (provision), net of federal (provision) benefit, Percentage	1.40%	(1.80%)	0.20%
Effective Income Tax Rate Reconciliation, Tax Credit, Amount	$ 67,726	$ 97,809	$ 118,877
Effective Income Tax Rate Reconciliation, Tax Credit, Percent	(92.10%)	(78.50%)	(10.10%)
Effect of changes in income tax rate applied to net deferred tax assets	$ (150)	$ (950)	$ (25,679)
Effect of changes in income tax rate applied to net deferred tax assets, Percentage	0.20%	0.80%	2.20%
Foreign tax rate difference	$ 46,102	$ 73,491	$ 148,932
Foreign tax rate difference, Percentage	(62.70%)	(59.00%)	(12.60%)
Foreign permanent differences, amount	$ (5,540)	$ (10,852)	$ 786
Foreign permanent differences, percent	7.50%	8.70%	(0.10%)
Change in valuation allowance	$ (7,537)	$ 385	$ 231
Change in valuation allowance, Percentage	10.20%	(0.30%)	(0.10%)
Effective income tax rate reconciliation, expiration of state attributes, amount	$ (1,947)	$ (1,962)	$ (3,048)
Effective income tax rate reconciliation, expiration of state attributes, percent	2.60%	1.60%	0.30%
Stock-based compensation	$ (10,696)	$ (9,036)	$ 11,148
Share-based compensation, Percentage	14.50%	7.20%	(0.90%)
Tax reserve adjustments	$ (8,451)	$ (9,437)	$ (3,262)
Tax reserve adjustments, Percentage	11.50%	7.60%	0.30%
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount	$ (129,692)	$ (128,708)	$ (130,874)
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent	176.40%	103.30%	11.10%
Effective income tax rate reconciliation, permanent reinvestment assertion, amount	$ (3,283)	$ (402)	$ (1,033)
Effective income tax rate reconciliation, permanent reinvestment assertion, percent	4.50%	0.30%	0.10%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent		0%	0%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Amount		$ 0	$ 0
Effective income tax rate reconciliation, Acquisition related adjustments, amount	$ (31,717)	$ (5,695)	$ (12,198)
Effective income tax rate reconciliation, Acquisition related adjustments, percent	43.20%	4.50%	1%
Other income tax benefit (expense)	$ 494	$ (2,207)	$ (1,695)
Other income tax benefit (expense), Percentage	(0.70%)	1.80%	0.10%
Income tax expense (benefit)	$ (143,882)	$ (21,477)	$ (147,731)
Total, Percentage	195.60%	17.20%	12.50%
fiscal year 2024
Decrease (increase) resulting from:
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Percent	58.10%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Restructuring Charges, Amount	$ 42,715

Income Taxes (Details 3)

Income Taxes (Details 3) - USD ($) $ in Thousands	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Deferred income tax assets:
Capitalized research and development expenses	$ 54,681	$ 57,048
Research and other tax credits	28,225	30,309
Employee benefits	16,290	24,374
Net operating loss carryforwards	25,563	22,189
Inventories	14,395	18,768
Total deferred income tax assets	212,927	214,215
Valuation allowance	(43,636)	(35,896)	$ (36,281)	$ (36,512)
Other	12,736	15,898
Total deferred income tax assets, net of valuation allowance	169,291	178,319
Deferred income tax liabilities:
Intangible assets	(71,912)	(69,050)
Property and equipment	(48,139)	(39,806)
Accrued tax on unremitted foreign earnings	(40,912)	(25,948)
Right-of-use assets	(13,301)	(17,457)
Other	3,834	2,645
Deferred Tax Assets, Net		23,413
Amounts included in consolidated balance sheets:
Other non-current assets	25,400	38,060
Other long-term liabilities	$ 34,207	$ 14,647

Income Taxes (Details 4)

Income Taxes (Details 4) - USD ($) $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Reconciliation of gross unrecognized tax benefits
Beginning balance	$ 152,331	$ 144,055	$ 134,068
Additions based on positions related to current year	5,298	9,718	11,826
Additions for tax positions in prior years	4,122	2,467	3,049
Reductions for tax positions in prior years	(2,416)	(363)	(1,669)
Expiration of statute of limitations	(436)	(3,546)	(3,219)
Ending balance	$ 158,899	$ 152,331	$ 144,055

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022	Apr. 03, 2021
Income Taxes (Textual)
Valuation Allowance	$ 43,636	$ 35,896	$ 36,281	$ 36,512
Valuation Allowance, Deferred Tax Asset, Change in Amount	(7,700)		(200)
Foreign jurisdiction exemption reduction, Dollar Amount	57,200	65,500
Gross unrecognized tax benefits	158,899	152,331	144,055	$ 134,068
Unrecognized tax benefits, if recognized, would impact the effective tax rate	152,600	145,900	137,500
Interest and penalties expense (benefit) recognized related to uncertain tax positions	(3,500)	(900)	5,100
Accrued interest and penalties related to unrecognized tax benefits	5,300	1,900	1,000
Long-term Tax Liability	43,900
Income tax expense (benefit)	143,882	21,477	147,731
Deferred Income Tax Expense (Benefit)	19,405	(66,145)	$ 31,875
domestic net operating losses and credits
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount		$ (400)
U.S. Federal
Income Taxes (Textual)
Loss carryovers	37,300
State
Income Taxes (Textual)
Loss carryovers	127,000
Research Tax Credit Carryforward [Member]
Income Taxes (Textual)
Income tax credits	89,500
Foreign deferred tax assets
Income Taxes (Textual)
Loss carryovers	101,000
State
Income Taxes (Textual)
Income tax credits	70,000
Foreign Tax Jurisdiction
Income Taxes (Textual)
Income tax credits	$ 8,900
Basic
Income Taxes (Textual)
Foreign jurisdiction exemption reduction, per share amount	$ 0.59	$ 0.64

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Numerator:
Numerator for basic and diluted net (loss) income per share - net (loss) income available to common stockholders	$ (70,322)	$ 103,152	$ 1,033,353
Denominator:
Denominator for basic net (loss) income per share — weighted average shares	97,557	102,206	110,196
Effect of dilutive securities:
Stock-based awards	0	813	1,350
Denominator for diluted net (loss) income per share — adjusted weighted average shares and assumed conversions	97,557	103,019	111,546
Basic net (loss) income per share	$ (0.72)	$ 1.01	$ 9.38
Diluted net (loss) income per share	$ (0.72)	$ 1	$ 9.26
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,500	800
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,500	800

Net Income (Loss) Per Share (_2

Net Income (Loss) Per Share (Details Textual) - shares shares in Millions	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023
Earnings Per Share [Abstract]
Shares excluded from the computation of diluted shares outstanding	1.5	0.8

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance at beginning balance, Shares	1,832
Balance at beginning balance, Weighted-Average Grant-Date Fair Value	$ 118.38
Granted, Shares	1,340
Granted, Weighted-Average Grant-Date Fair Value	$ 102.14
Vested, Shares	(830)
Vested, Weighted-Average Grant-Date Fair Value	$ 112.19
Forfeited, Shares	(118)
Forfeited, Weighted-Average Grant-Date Fair Value	$ 115.85
Balance at ending balance, Shares	2,224	1,832
Balance at ending balance, Weighted-Average Grant-Date Fair Value	$ 111.32	$ 118.38
Outstanding beginning balance, Shares	69
Outstanding beginning balance, Weighted-Average Exercise Price	$ 20.95
Granted, Shares	0
Granted, Weighted-Average Exercise Price	$ 0
Exercised, Shares	(66)
Exercised, Weighted-Average Exercise Price	$ 20.13
Canceled, Shares	(2)
Canceled, Weighted-Average Exercise Price	$ 15.47
Forfeited, Shares	0
Forfeited, Weighted-Average Exercise Price	$ 0
Outstanding ending balance, Shares	1	69
Outstanding ending balance, Weighted-Average Exercise Price	$ 67.84	$ 20.95
Outstanding ending balance, Weighted-Average Remaining Contractual Term	9 months 29 days
Outstanding ending balance, Aggregate Intrinsic Value	$ 65
Vested and expected to vest, Shares	1
Vested and expected to vest, Weighted-Average Exercise Price	$ 67.84
Vested and expected to vest, Weighted-Average Remaining Contractual Term	9 months 29 days
Vested and expected to vest, Aggregate Intrinsic Value	$ 65
Options exercisable, Shares	1
Options exercisable, Weighted-Average Exercise Price Ending Balance	$ 67.84
Options exercisable, Weighted-Average Remaining Contractual Term Ending Balance	9 months 29 days
Options exercisable, Aggregate Intrinsic Value	$ 65
Number of shares available for grant or issuance	3,088
Shares granted	0
Stock-based compensation expense	$ 120,834	$ 105,580	$ 83,507
Closing stock price				$ 114.83
Total intrinsic value of options exercised	5,100	16,500	27,100
Cash received from the exercise of stock options (excluding accrued unremitted employee funds)	$ 36,400
Annual forfeiture rate	1.40%
Total remaining unearned compensation cost related to nonvested restricted stock unit	$ 0
Total fair value of vested restricted stock units	85,800	$ 74,100	$ 163,600
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total remaining unearned compensation cost related to nonvested restricted stock unit	$ 159,400
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units	1 year 4 months 24 days
Vesting period	4 years
Performance and service-based restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	2 years
Certain officers of the Company (Section 16 Officers)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Shares	400
Shares granted	400
Stock-based compensation expense	$ 34,700
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	2,200
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	85%
Shares issued under plan	500	300
Share-Based Compensation Arrangement by Share-Based Payment Award, Cash Contribution	$ 0
2009 and 2012 Incentive Plans - TriQuint
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0
2013 Incentive Plan - Qorvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0
2012 Stock Incentive Plan - Qorvo
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	0
2022 Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant or issuance	3,100
Maximum number of shares of common stock to be issued under plan	4,500
2022 Incentive Plan | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum number of shares of common stock to be issued under plan	200

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) shares in Thousands, $ in Millions	Mar. 30, 2024	Apr. 01, 2023	Nov. 02, 2022
Common stock reserved for future issuance
Outstanding stock options under formal directors’ and employees’ stock option plans	1	69
Possible future issuance under Company stock incentive plans	3,088
Employee stock purchase plan	2,160
Restricted stock-based units granted	2,224	1,832
Total shares reserved	7,472
Nov. 2022 Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Repurchase Program, Authorized Amount			$ 2,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 1,305

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 30, 2024	Apr. 01, 2023	Apr. 02, 2022
Shareholders' Equity (Textual)
Stock Repurchased During Period, Shares	(3,959)	(8,664)	(7,306)
Document Fiscal Year Focus	2024
Stock Repurchased During Period, Value	$ 402,975	$ 862,200	$ 1,152,287
Document Period End Date	Mar. 30, 2024
Common stock reserved for future issuance	7,472
Common stock, shares authorized	405,000	405,000
Common Stock [Member]
Shareholders' Equity (Textual)
Stock Repurchased During Period, Value	$ 299,204	$ 331,406	$ 276,035

Operating Segment and Geograp_3

Operating Segment and Geographical Information (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)	Mar. 30, 2024 USD ($)	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)
Segment Reporting Information [Line Items]
Goodwill impairment	$ 173,400	$ 48,000	$ 221,414	$ 12,411	$ 48,000
Revenues			3,769,506	3,569,399	4,645,714
Operating income			91,701	183,168	1,226,069
Interest expense			(69,245)	(68,463)	(63,326)
Other income, net			51,104	9,924	18,341
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest			73,560	124,629	1,181,084
Long-lived tangible assets			870,982	1,149,806
Share-based Payment Arrangement, Noncash Expense			(120,834)	(105,580)	(83,507)
Amortization of Intangible Assets			(127,898)	(132,425)	(150,466)
Capitalized Contract Cost, Impairment Loss			38,400	181,000
Disposal Group, Including Discontinued Operation, Property, Plant and Equipment			$ 133,425
Number of Reportable Segments			3
United States
Segment Reporting Information [Line Items]
Revenues			$ 2,175,937	1,817,960	1,928,403
CHINA
Segment Reporting Information [Line Items]
Revenues			726,810	741,405	1,499,212
Other Asia
Segment Reporting Information [Line Items]
Revenues			517,683	498,966	620,620
TAIWAN, PROVINCE OF CHINA
Segment Reporting Information [Line Items]
Revenues			260,839	308,642	345,869
Europe
Segment Reporting Information [Line Items]
Revenues			88,237	202,426	251,610
Geographic Concentration Risk [Member] | Property, Plant and Equipment | United States
Segment Reporting Information [Line Items]
Long-lived tangible assets			795,466	929,446
Geographic Concentration Risk [Member] | Property, Plant and Equipment | CHINA
Segment Reporting Information [Line Items]
Long-lived tangible assets			18,563	169,215
Geographic Concentration Risk [Member] | Property, Plant and Equipment | Other Countries
Segment Reporting Information [Line Items]
Long-lived tangible assets			56,953	51,145
All other
Segment Reporting Information [Line Items]
Goodwill impairment				12,411	48,000
Operating income			(630,057)	(571,280)	(325,574)
Share-based Payment Arrangement, Noncash Expense			(120,834)	(105,580)	(83,507)
Amortization of Intangible Assets			(121,809)	(132,126)	(150,128)
Restructuring Costs			92,764	114,094	2,121
Business Combination, Acquisition And Integration related costs			(11,172)	(23,311)	(27,964)
Capitalized Contract Cost, Impairment Loss			38,419	181,000	0
Other Unallocated Income Expense			(23,645)	(2,758)	(13,854)
HPA
Segment Reporting Information [Line Items]
Goodwill impairment			0
HPA | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues			572,953	727,187	707,395
Operating income			82,501	198,820	210,441
CSG
Segment Reporting Information [Line Items]
Goodwill impairment			221,414
CSG | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues			434,537	474,364	703,881
Operating income			(88,649)	(72,080)	107,814
ACG
Segment Reporting Information [Line Items]
Goodwill impairment			0
ACG | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues			2,762,016	2,367,848	3,234,438
Operating income			$ 727,906	$ 627,708	$ 1,233,388